Home
  >  
Section 44

EurekaMag Full Text Articles Chapter 43,504



References:

Hermann, G.; Goldblatt, J.; Desnick, R.J. 1984: Kümmell disease: delayed collapse of the traumatised spine in a patient with Gaucher type 1 disease. British Journal of Radiology 57(682): 833-835
Brower, A.C.; Downey, E.F. 1981: Kümmell disease: report of a case with serial radiographs. Radiology 141(2): 363-364
Lindholm, R.V.; Küntscher, G. 1980: Küntscher bone nailing -- forecast and actuality. Annales Chirurgiae et Gynaecologiae 69(3): 85-91
Christensen, N.O. 1973: Küntscher intramedullary reaming and nail fixation for non-union of fracture of the femur and the tibia. Journal of Bone and Joint Surgery. British Volume 55(2): 312-318
Mai, B.M. 1980: Küntscher nail extraction apparatus. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 51(11): 735-736
Valdiserri, L.; Marchiodi, L.; Rubbini, L. 1983: Küntscher nailing in the treatment of femoral fractures in children. Is it completely contraindicated?. Italian Journal of Orthopaedics and Traumatology 9(3): 293-296
Broad, C.P.; Hamami, M.N. 1980: Küntscher nailing of femoral fractures associated with Austin Moore's prosthesis. Injury 12(3): 252-255
King, R. 1980: Küntscher nailing of the tibia--a new tibial jig. Injury 11(3): 256-257
Bortolotti, E. 1966: Küntscher's bone marrow osteosynthesis in diaphyseal fractures: considerations on treatment. Minerva Ortopedica 17(8): 486-495
Schroth, R. 1969: Küntscher's closed intramedullary nailing. Zentralblatt für Chirurgie 94(40): 1332-1335
Sakurai, O. 1970: Küntscher's intramedular pin fixation. Shujutsu. Operation 24(1): 65-71
Eilenberger, S. 1982: Küntscher's intramedullary nailing of upper arm shaft fractures. Die Medizinische Welt 33(44): 1542-1544
Zimmermann, H.G. 1981: Küntscher's intramedullary nailing. An alternative method in the treatment of femoral fractures close to the knee joint in the aged. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 52(8): 535-537
Harrold, A.J. 1982: Küntscher's nails for femoral fractures. British Medical Journal 285(6353): 1446
Grigar, L. 1981: Küntscher's syndrome. Ceskoslovenska Radiologie 35(1): 68-70
Anonymous 1967: Küttner's syndrome. Jibi Inkoka Otolaryngology 39(12): 1319
Pouillart, P.; Huong, T.H.; Lhéritier, J. 1974: L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias. Bulletin du Cancer 61(4): 509-526
Ikeda, Y.; Toyama, K.; Matsuki, S.; Asano, S.; Aiba, M. 1973: L Bence Jones type multiple myeloma associated with amyloidosis and ileus: a case report. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 62(3): 274-279
Forsythe-Jauch, W.E.; Farmer, J.J. 1981: L CPL Joseph John Farmer, VC, AHC. Centenary of the battle of Majuba 1881. Journal of the Royal Army Medical Corps 127(2): 100-102
Gisselmann, A.; Lacroix, B.; Lamy, A.; Loche, D. 1972: L Dopa and neurologic comas. La Nouvelle Presse Medicale 1(34): 2248
Marek, J.; Thoenes, W.; Motlík, K. 1970: L [Lipoid transformation of adrenocortical mitochondria in the rat after aminoglutethimide (Elipten Ciba). Virchows Archiv. B Cell Pathology 6(2): 116-131
Hartmann, L.; Gali, P. 1982: L and M isoenzymes of hepatic pyruvate kinase and their hormone dependence. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 176(6): 804-816
Frangione, B.; Franklin, E.C.; Kelus, A.S. 1968: L chain peptide maps of rabbit IgG of different allotypes. Immunology 15(4): 599-607
Greenblatt, J.; Li, J.; Adhya, S.; Friedman, D.I.; Baron, L.S.; Redfield, B.; Kung, H.F.; Weissbach, H. 1980: L factor that is required for beta-galactosidase synthesis is the nusA gene product involved in transcription termination. Proceedings of the National Academy of Sciences of the United States of America 77(4): 1991-1994
Roberts, R.B. 1966: L form of Neisseria gonorrhoeae. Journal of Bacteriology 92(6): 1609-1614
Stadtsbaeder, S.; Gilain, A. 1971: L forms. Acta Clinica Belgica. Supplementum 7: 102-105
Chattman, M.S.; Mattman, L.H.; Mattman, P.E. 1969: L forms in blood cultures demonstrated by nucleic acid fluorescence. American Journal of Clinical Pathology 51(1): 41-50
Moroni, M.; Medina, F. 1968: L forms in infectious pathology: literature review and personal experience. Giornale di Malattie Infettive E Parassitarie 20(10): 864-876
Kagan, B.M. 1971: L forms in patients with cystic fibrosis. American Review of Respiratory Disease 103(5): 727-728
Gumpert, J.; Schuhmann, E.; Taubeneck, U. 1971: L forms of Escherichia coli K 12 (lambda). Electronoptic studies. Zeitschrift für Allgemeine Mikrobiologie 11(4): 283-300
Schuhmann, E.; Taubeneck, U. 1971: L forms of Escherichia coli K 12 (lambda). I. Induction and mode of multiplication. Zeitschrift für Allgemeine Mikrobiologie 11(3): 205-219
Bogush, L.K.; Karachunskiĭ, M.A.; Dorozhkova, I.R.; Zhangireev, A.A.; Abramov, E.L. 1981: L forms of Mycobacterium tuberculosis in chronic pleural empyema in tuberculosis patients. Problemy Tuberkuleza 12: 19-23
Serra, P.; Panichi, G.; Martino, P.; Brandimarte, C.; Capocaccia, L. 1971: L forms of bacteria. I. Cultural characteristics of L forms of Staphylococcus aureus and Streptococcus liquefaciens. Annali Sclavo; Rivista di Microbiologia E di Immunologia 13(4): 425-438
Serra, P.; Panichi, G.; Martino, P.; Brandimarte, C.; Capocaccia, L. 1971: L forms of bacteria. II. Quantitative aspects of the induction on agar of Staphylococcus aureus and Streptococcus liquefaciens in L phase. Annali Sclavo; Rivista di Microbiologia E di Immunologia 13(4): 439-446
Louria, D.B. 1971: L forms, spheroplasts and aberrant forms in chronic sepsis. Advances in Internal Medicine 17: 125-142
Shuklinov, V.A.; Livshits, V.L.; Shumilina, V.V.; Tregubova, N.A.; Isakova, L.M. 1980: L line cell differentiation. Histochemical and electron microscopic studies. Tsitologiia 22(7): 804-809
Wright, S.R. 1972: L x-ray measurement of actinide metabolism using 243 Am in mice. International Journal of Applied Radiation and Isotopes 23(9): 423-429
Castelot, A.; Napoleon II 1966: L'Aiglon, victim of medicine? According to further documents. La Presse Medicale 74(51): 2651-2652
Migel, D. 1969: L'Hopital Albert Schweitzer in Haiti. Northwest Medicine 68(5): 490-491
Dumas, P. 1965: L'Hotel-Dieu de Montreal and French-Canadian medicine today. L'Union Medicale du Canada 94(6): 763-765
Barth, K.H.; Brusilow, S.W.; Kaufman, S.L.; Ferry, F.T. 1981: Percutaneous transluminal angioplasty of homograft renal artery stenosis in a 10-year-old girl. Pediatrics 67(5): 675-677
Combes, F. 1969: L'Hôpital Thermal des Armées of Lamalou-Les-Bains: double mission. La Presse Thermale et Climatique 106(2): 93-98
Tazawa, I.; Tazawa, S.; Stempel, L.M.; Ts'o, P.O. 1970: L'adenylyl-(3'-5')-L-adenosine and L-adenylyl-(2'-5')-L-adenosine. Biochemistry 9(18): 3499-3514
Shraberg, D.; Weitzel, W.D.; Shingleton, D. 1980: L'illusion de Capgras--syndrome or phenomenon?. Journal of the Kentucky Medical Association 78(3): 125-127
Boncio, L.; Pitzurra, M.; Bistoni, F.; Binazzi, M. 1974: L'indice microbico cutaneo (I.M.C.). Annali Sclavo; Rivista di Microbiologia E di Immunologia 16(5): 507-522
Fourcroy, J.L. 1983: L'éternel couteau: review of female circumcision. Urology 22(4): 458-461
Eichel, B.; Lisanti, V.F.; Skolnick, K.; Sulkin, M.D.; Wertheimer, A.B. 1965: L(+)-Lactate dehydrogenase in the human oral cavity. Annals of the new York Academy of Sciences 131(2): 851-867
McCullagh, K.J.; Bonen, A. 1995: L(+)-lactate binding to a protein in rat skeletal muscle plasma membranes. Canadian Journal of Applied Physiology 20(1): 112-124
Eichel, B.; Shahrik, H.A.; Chodosh, S.; Medici, T.C.; Burgi, H. 1972: L(+)-lactate dehydrogenase in sputum from patients with chronic obstructive lung diseases. Journal of Laboratory and Clinical Medicine 79(3): 461-469
Paul, S.E.; Richardson, K.E. 1969: L(+)-tartrate inhibition of acid phosphatase isozymes from rat prostate. Investigative Urology 7(3): 232-239
Smith, G.K.; Benkovic, P.A.; Benkovic, S.J. 1981: L(-)-10-Formyltetrahydrofolate is the cofactor for glycinamide ribonucleotide transformylase from chicken liver. Biochemistry 20(14): 4034-4036
Witiak, D.T.; Muhi-Eldeen, Z.; Mahishi, N.; Sethi, O.P.; Gerald, M.C. 1971: L(S)- and D(R)-3-amino-1-phenylpyrrolidines. Stereoselective antagonists for histamine and acetylcholine receptors in vitro. Journal of Medicinal Chemistry 14(1): 24-30
Horita, A.; Nair, X.; Hamilton, A.E. 1972: L- -methyl- -hydrazino- -(3,4-dihydroxyphenyl)propionic acid: relative lack of antidecarboxylase activity in adrenals. Science 176(4037): 931-932
Atkinson, E.R.; Mc Ritchie, D.L.; Soloway, A.H. 1966: L-(+)-2-beta-Tropanyl diphenylborinate. Journal of Medicinal Chemistry 9(3): 412-414
Annett, R.G.; Stumpf, P.K. 1972: L-(-)-Menthyloxycarbonyl derivatization of hydroxy acid methyl esters. Analytical Biochemistry 47(2): 638-640
Watanabe, S.; Mitsunobu, K.; Sannomiya, T.; Otsuki, S. 1970: L-(U-14C) tyrosine metabolism of the perfused cat brain with high plasma phenylalanine or without plasma tyrosine. Folia Psychiatrica et Neurologica Japonica 24(4): 219-226
Larizza, A.; Brancaccio, G.; Segre, A. 1966: L-, D-, and DL-ephedrine phosphates. Journal of Medicinal Chemistry 9(6): 966-967
Temptamy, S.; Safwat-Skoukry, A.; El-Meligy, R. 1974: L--pfeiffer syndrome. Birth Defects Original Article Series 10(5): 229-236
Onishi, N.; Watanabe, T.; Izaki, K.; Takahashi, H. 1982: L-1,4-cyclohexadiene-1-alanine, an antimetabolite of l-phenylalanine produced by a Pseudomonas. Journal of Antibiotics 35(7): 903-904
Sufrin, J.R.; Lombardini, J.B.; Keith, D.D. 1982: L-2-Amino-4-methoxy-cis-but-3-enoic acid, a potent inhibitor of the enzymatic synthesis of S-adenosylmethionine. Biochemical and Biophysical Research Communications 106(2): 251-255
Duran, M.; Kamerling, J.P.; Bakker, H.D.; van Gennip, A.H.; Wadman, S.K. 1980: L-2-Hydroxyglutaric aciduria: an inborn error of metabolism?. Journal of Inherited Metabolic Disease 3(4): 109-112
Saugstad, J.A.; Segerson, T.P.; Westbrook, G.L. 1995: L-2-amino-3-phosphonopropionic acid competitively antagonizes metabotropic glutamate receptors 1 alpha and 5 in Xenopus oocytes. European Journal of Pharmacology 289(2): 395-397
Lindner, E. 1984: L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity. Arzneimittel-Forschung 34(3): 270-276
Melamed, E.; Hefti, F.; Wurtman, R.J. 1980: L-3,4-Dihydroxyphenylalanine and L-5-hydroxytryptophan decarboxylase activities in rat striatum: effect of selective destruction of dopaminergic or serotoninergic input. Journal of Neurochemistry 34(6): 1753-1756
Rivera-Calimlim, L.; Morgan, J.P.; Dujovne, C.A.; Bianchine, J.R.; Lasagna, L. 1971: L-3,4-dihydroxyphenylalanine metabolism by the gut in vitro. Biochemical Pharmacology 20(11): 3051-3057
Landsberg, L. 1971: L-3,4-dihydroxyphenylalanine-induced of norepinephrine from the rat heart. Biochemical Pharmacology 20(12): 3542-3547
Scannell, J.P.; Pruess, D.L.; Demny, T.C.; Williams, T.; Stempel, A. 1970: L-3-(2,5-dihydrophenyl)alanine, an antimetabolite of L-phenylalanine produced by a streptomycete. Japanese Journal of Antibiotics 23(6): 618-619
Kloster, G.; Bockslaff, H. 1982: L-3-123I-alpha-methyltyrosine for melanoma detection: a comparative evaluation. International Journal of Nuclear Medicine and Biology 9(4): 259-269
Noyes, B.E.; Bradshaw, R.A. 1973: L-3-hydroxyacyl coenzyme a dehydrogenase from pig heart muscle. I. Purification and properties. Journal of Biological Chemistry 248(9): 3052-3059
Noyes, B.E.; Bradshaw, R.A. 1973: L-3-hydroxyacyl coenzyme a dehydrogenase from pig heart muscle. II. Subunit structure. Journal of Biological Chemistry 248(9): 3061-3066
Lapidus, M.; Sweeney, M. 1973: L-4'-Cyano-3-(2,2,2-trifluoroacetamido)succinanilic acid and related synthetic sweetening agents. Journal of Medicinal Chemistry 16(2): 163-166
Stapley, E.O.; Miller, T.W.; Mata, J.M.; Hendlin, D. 1967: L-4-oxalysine, and antimetabolic antibiotic of microbial origin. Antimicrobial Agents and ChemoTherapy 7: 401-406
Bonaduce, D.; Covino, E.; Canonico, V.; De Caprio, L.; Ferrara, N.; Spampinato, N.; Rengo, F.; Condorelli, M. 1983: Effectiveness of the aorto-coronary by-pass procedure in elderly patients. Giornale Italiano di Cardiologia 13(5): 361-365
Heffernan, L.P.; Fraser, R.C.; Purdy, R.A. 1980: L-5 radiculopathy secondary to a uterine leiomyoma in a primigravid patient. American Journal of Obstetrics and Gynecology 138(4): 460-461
Threatte, R.M.; Fregly, M.J.; Connor, T.M.; Kikta, D.C. 1981: L-5-Hydroxytryptophan-induced drinking in rats: possible mechanisms for induction. Pharmacology Biochemistry and Behavior 14(3): 385-391
Abraham, H.D. 1983: L-5-hydroxytryptophan for LSD-induced psychosis. American Journal of Psychiatry 140(4): 456-458
Sano, I. 1972: L-5-hydroxytryptophan(L-5-HTP) therapy in endogenous depression. 1. Münchener Medizinische Wochenschrift 114(40): 1713-1716
Sano, I.; Taniguchi, K. 1972: L-5-hydroxytryptophan(L-5-HTP) therapy of Parkinson's disease. 2. Münchener Medizinische Wochenschrift 114(40): 1717-1719
Sano, I. 1972: L-5-hydroxytryptophan-(L-5-HTP) therapy. Folia Psychiatrica et Neurologica Japonica 26(1): 7-17
Löscher, W.; Pagliusi, S.R.; Müller, F. 1984: L-5-hydroxytryptophan. Correlation between anticonvulsant effect and increases in levels of 5-hydroxyindoles in plasma and brain. Neuropharmacology 23(9): 1041-1048
Bono, G.; Micieli, G.; Sances, G.; Calvani, M.; Nappi, G. 1984: L-5HTP treatment in primary headaches: an attempt at clinical identification of responsive patients. Cephalalgia: An International Journal of Headache 4(3): 159-165
Williams, M.; Martin, G.E.; Remy, D.C.; Hichens, M.; Mangel, A.W.; Taylor, D.A.; Yarbrough, G.G.; Bendesky, R.J.; King, S.W.; Robinson, J.L. 1984: L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems. Journal of Pharmacology and Experimental Therapeutics 229(3): 775-781
Singh, J. 1984: L-Alanine and L-phenylalanine activate Na+ and K+ conductance pathways in the exocrine mouse pancreas. Pflugers Archiv: European Journal of Physiology 402(2): 176-184
Beck, C.S.; Hasinoff, C.W.; Smith, M.E. 1968: L-Alanyl-beta-naphthylamidase in rat spinal cord myelin. Journal of Neurochemistry 15(11): 1297-1301
Gomi, K.; Beppu, T.; Arima, K. 1980: L-Alloisocitrate dehydrogenase and oxalosuccinate decarboxylase from a Pseudomonas sp. utilizing L-alloisocitrate. Journal of Biochemistry 87(5): 1439-1448
Jayaraman, K.; Monteal, J.; Paulus, H. 1969: L-Alpha,gamma-diaminobutyrate-activating enzyme from Bacillus polymyxa. Properties and distribution. Biochimica et Biophysica Acta 185(2): 447-457
Sanders, R.B.; Abulaban, F.S. 1971: L-Amino acid inhibition of epinephrine-induced hyperglycemia. Pharmacology 6(3): 155-163
Pedrosa, F.O.; Zancan, G.T. 1974: L-Arabinose metabolism in Rhizobium japonicum. Journal of Bacteriology 119(1): 336-338
Hogg, R.W. 1982: L-Arabinose- and D-galactose-binding proteins from Escherichia coli. Methods in Enzymology 90 Pt E: 463-467
Newcomer, M.E.; Gilliland, G.L.; Quiocho, F.A. 1981: L-Arabinose-binding protein-sugar complex at 2.4 a resolution. Stereochemistry and evidence for a structural change. Journal of Biological Chemistry 256(24): 13213-13217
Deguchi, T.; Yoshioka, M. 1982: L-Arginine identified as an endogenous activator for soluble guanylate cyclase from neuroblastoma cells. Journal of Biological Chemistry 257(17): 10147-10151
Campbell, H.A.; Mashburn, L.T. 1969: L-Asparaginase EC-2 from Escherichia coli. Some substrate specificity characteristics. Biochemistry 8(9): 3768-3775
Nesbit, M.E.; Ertel, I.; Hammond, G.D. 1981: L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group. Cancer Treatment Reports 65(Suppl 4): 101-107
Derezić, D.; Silobrcić, V. 1974: L-Asparaginase as an immunosuppresive agent. Lijecnicki Vjesnik 96(8): 481-488
Shifrin, S.; Solis, B.G.; Chalken, I.M. 1973: L-Asparaginase from Erwinia carotovora. Physicochemical properties of the native and succinylated enzyme. Journal of Biological Chemistry 248(10): 3464-3469
Shifrin, S.; Luborsky, S.W.; Grochowski, B.J. 1971: L-Asparaginase from Escherichia coli B. Physicochemical studies of the dissociation process. Journal of Biological Chemistry 246(24): 7708-7714
Tosa, T.; Sano, R.; Yamamoto, K.; Nakamura, M.; Ando, K. 1971: L-Asparaginase from Proteus vulgaris. Applied Microbiology 22(3): 387-392
Tosa, T.; Sano, R.; Yamamoto, K.; Nakamura, M.; Chibata, I. 1973: L-Asparaginase from Proteus vulgaris. Subunit and amino acid composition. Biochemistry 12(6): 1075-1079
Shifrin, S.; Grochowski, B.J. 1972: L-Asparaginase from escherichia coli B. Succinylation and subunit interactions. Journal of Biological Chemistry 247(4): 1048-1054
Soru, E.; Teodorescu, M.; Zaharia, O.; Szabados, J.; Rudescu, K. 1972: L-Asparaginase from the BCG strain of Mycobacterium bovis. I. Purification and in vitro immunosuppressive properties. Canadian Journal of Biochemistry 50(11): 1149-1157
Mathé, G.; Amiel, J.L.; Clarysse, A.; Hayat, M.; Schwarzenberg, L.; Schneider, M. 1970: L-Asparaginase in the treatment of acute leukemia. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 46(17): 1135-1140
DeJong, P.J. 1972: L-Asparaginase production by Streptomyces griseus. Applied Microbiology 23(6): 1163-1164
Kafkewitz, D.; Goodman, D. 1974: L-Asparaginase production by the rumen anaerobe Vibrio succinogenes. Applied Microbiology 27(1): 206-209
Liu, F.S.; Zajic, J.E. 1972: L-Asparaginase synthesis by Erwinia aroideae. Applied Microbiology 23(3): 667-668
Lavine, R.L.; Dicintio, D.M. 1980: L-Asparaginase-induced diabetes mellitus in rabbits. Diabetes 29(7): 528-531
Broome, J.D. 1981: L-Asparaginase: discovery and development as a tumor-inhibitory agent. Cancer Treatment Reports 65 Suppl. 4: 111-114
Haskell, C.M. 1981: L-Asparaginase: human toxicology and single agent activity in nonleukemic neoplasms. Cancer Treatment Reports 65(Suppl 4): 57-59
Sharif, N.A.; Roberts, P.J. 1981: L-Aspartate binding sites in rat cerebellum: a comparison of the binding of L-[3H]aspartate and L-[3H]glutamate to synaptic membranes. Brain Research 211(2): 293-303
Nasu, S.; Wicks, F.D.; Gholson, R.K. 1982: L-Aspartate oxidase, a newly discovered enzyme of Escherichia coli, is the B protein of quinolinate synthetase. Journal of Biological Chemistry 257(2): 626-632
Marvizón, J.G.; Mayor, F.; Aragón, M.C.; Giménez, C.; Valdivieso, F. 1981: L-Aspartate transport into plasma membrane vesicles derived from rat brain synaptosomes. Journal of Neurochemistry 37(6): 1401-1406
MacDonald, J.F.; Porietis, A.V.; Wojtowicz, J.M. 1982: L-Aspartic acid induces a region of negative slope conductance in the current-voltage relationship of cultured spinal cord neurons. Brain Research 237(1): 248-253
Rebouche, C.J.; Mack, D.L.; Edmonson, P.F. 1984: L-Carnitine dissimilation in the gastrointestinal tract of the rat. Biochemistry 23(26): 6422-6426
Chalmers, R.A.; Stacey, T.E.; Tracey, B.M.; de Sousa, C.; Roe, C.R.; Millington, D.S.; Hoppel, C.L. 1984: L-Carnitine insufficiency in disorders of organic acid metabolism: response to L-carnitine by patients with methylmalonic aciduria and 3-hydroxy-3-methylglutaric aciduria. Journal of Inherited Metabolic Disease 7(Suppl 2): 109-110
Floud, A.; Fahn, S. 1981: L-DOPA (L-3,4-dihydroxyphenylalanine) uptake by human red blood cells. Biochimica et Biophysica Acta 645(2): 165-169
Narabayashi, H.; Kosaka, K. 1971: L-DOPA administration in parkinsonism. Naika. Internal Medicine 28(3): 436-439
Ferko, A.P.; Calesnick, B. 1971: L-DOPA and dopamine on skeletal muscle. Research Communications in Chemical Pathology and Pharmacology 2(2): 146-153
Hayek, A.; Crawford, J.D. 1972: L-DOPA and pituitary hormone secretion. Journal of Clinical Endocrinology and Metabolism 34(5): 764-766
Dafny, N.; Gilman, S. 1973: L-DOPA and reserpine: effects on evoked potentials in basal ganglia of freely moving rats. Brain Research 50(1): 187-191
Frantz, A.G.; Suh, H.K. 1974: L-DOPA and the control of prolactin secretion. Advances in Neurology 5: 447-456
Millar, J.G.; Kurtz, A.; Aminoff, M.J.; Wilcox, C.S.; Nabarro, J.D. 1973: L-DOPA as a test of anterior pituitary function. Journal of Endocrinology 59(2): xxv-xxvi
McDowell, F.H.; Lee, J.E. 1970: L-DOPA in Parkinson's Disease. California Medicine 113(4): 44-46
Mars, H.; Libman, I.; Schwartz, A.M.; Gillo-Joffroy, L.; Barbeau, A. 1972: L-DOPA in Parkinson's disease. Results of a co-operative study in the Montreal area. Canadian Psychiatric Association Journal 17(2): 123-131
Persson, T.; Wålinder, J. 1971: L-DOPA in the treatment of depressive symptoms. British Journal of Psychiatry: the Journal of Mental Science 119(550): 277-278
Plewig, G. 1972: L-DOPA in therapy of common acne. Der Hautarzt; Zeitschrift für Dermatologie Venerologie und verwandte Gebiete 23(10): 474
Strömberg, U.; Svensson, T.H. 1971: L-DOPA induced effects on motor activity in mice after inhibition of dopamine-beta-hydroxylase. Psychopharmacologia 19(1): 53-60
Gouret, C.; Raynaud, G. 1973: L-DOPA jumping test in mice: its use in the study of antagonistic psychotropic drugs. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 167(10): 1360-1366
Warner, C.; Brown, L.L.; Wolfson, L.I. 1982: L-DOPA produces regional changes in glucose utilization which form discrete anatomic patterns in motor nuclei and the hypothalamus of rats. Experimental Neurology 78(3): 591-601
Spaulding, S.W.; Burrow, G.N.; Donabedian, R.; van Woert, M. 1972: L-DOPA suppression of thyrotropin-releasing hormone response in man. Journal of Clinical Endocrinology and Metabolism 35(1): 182-185
Kimura, N.; Tsukue, I. 1971: L-DOPA therapy in drug-induced parkinsonism evaluated by the method measuring the facial expression. Hiroshima Journal of Medical Sciences 20(1): 55-63
Sutcliffe, R.L. 1973: L-DOPA therapy in elderly patients with parkinsonism. Age and Ageing 2(1): 34-38
Stam, F.C.; Heslinga, F.J. 1970: L-DOPA therapy in patients with parkinsonism. Nederlands Tijdschrift Voor Geneeskunde 114(20): 849-852
Mel'nichuk, P.V.; Sosnovskaia, L.S. 1973: L-DOPA therapy of deforming muscular dystonia in children. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 73(10): 1495-1498
Barbeau, A. 1970: L-DOPA therapy past, present and future. Arizona Medicine 27(7): 1-4
Jonas, S. 1971: L-DOPA treatment for Parkinsonism: analysis of functional improvement. Archives of Physical Medicine and Rehabilitation 52(12): 560-562
Davidson, L.; Lloyd, K.; Dankova, J.; Hornykiewicz, O. 1971: L-DOPA treatment in Parkinson's disease: effect on dopamine and related substances in discrete brain regions. Experientia 27(9): 1048-1049
Di Rocco, C.; Maira, G.; Meglio, M.; Rossi, G.F. 1974: L-DOPA treatment of comatose states due to cerebral lesions. Preliminary findings. Journal of Neurosurgical Sciences 18(3): 169-176
Ando, K.; Kono, K.; Sofue, I. 1973: L-DOPA treatment of parkinsonism: analysis of the clinical course in follow-up cases. Nihon Rinsho. Japanese Journal of Clinical Medicine 31(10): 2980-2986
Lakke, J.P.; Nienhuis, R.J.; Meyer, R.; Zwols, F.; Schut, T. 1972: L-DOPA with the decarboxylase inhibitor Ro 4-4602 in the treatment of Parkinson's disease. Nederlands Tijdschrift Voor Geneeskunde 116(48): 2180-2184
Goodwin, F.K.; Murphy, D.L.; Brodie, H.K.; Bunney, W.E. 1970: L-DOPA, catecholamines, and behavior: a clinical and biochemical study in depressed patients. Biological Psychiatry 2(4): 341-366
Fujimori, N.; Kito, S.; Yamamoto, M.; Itoga, E.; Kosaka, K. 1974: L-DOPA-and dopa-decarboxylase inhibitor combination for the treatment of Parkinsonism. Nihon Rinsho. Japanese Journal of Clinical Medicine 32(3): 579-586
Derkach, P.; Larochelle, L.; Bieger, D.; Hornykiewicz, O. 1974: L-DOPA-chlorpromazine antagonism on running activity in mice. Canadian Journal of Physiology and Pharmacology 52(1): 114-118
Brokken, B.; Lewis, F.I.; Martin, W.E. 1969: L-DOPA: a nursing adventure. Nursing Clinics of North America 4(4): 733-742
Friedman, E.; Gershon, S. 1972: L-DOPA: centrally mediated emission of seminal fluid in male rats. Life Sciences.(Part 1): Physiology and Pharmacology 11(9): 435-440
Brossi, A.; Pool, W.; Sheppard, H.; Burns, J.J.; Kaiser, A.; Bigler, R.; Bartholini, G.; Pletscher, A. 1974: L-DOPA: chemical modifications and biological evaluation. Advances in Neurology 5: 291-293
Kurtz, D.J.; Kanfer, J.N. 1971: L-DOPA: effect on cerebral pyridoxal phosphate content and coenzyme activity. Journal of Neurochemistry 18(11): 2235-2236
Mendlewicz, J.; Youdim, M.B. 1983: L-Deprenil, a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation. British Journal of Psychiatry: the Journal of Mental Science 142: 508-511
Yahr, M.D.; Duvoisin, R.C.; Hoehn, M.M.; Schear, M.J.; Barrett, R.E. 1968: L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. Transactions of the American Neurological Association 93: 56-63
Friedman, E.; Gershon, S. 1972: L-Dopa and imipramine: biochemical and behavioral interaction. European Journal of Pharmacology 18(2): 183-188
Cheal, M. 1983: L-Dopa and piribedil alter different components of attentional behavior dependent on dose. Psychopharmacology 80(4): 345-350
Tran, N. 1972: L-Dopa and pyridoxine. Lancet 2(7766): 45-46
Wedig, J.H.; Gay, V.L. 1974: L-Dopa as a stimulus for LH release in the proestrous rat: blockade of its action by pentobarbital anesthesia. Neuroendocrinology 15(2): 99-105
Dickey, R.P.; Minton, J.P. 1972: L-Dopa effect on prolactin, follicle-stimulating hormone, and luteinizing hormone in women with advanced breast cancer: a preliminary report. American Journal of Obstetrics and Gynecology 114(2): 267-269
Cotzias, G.C. 1968: L-Dopa for Parkinsonism. New England Journal of Medicine 278(11): 630
Brockmann, A.W. 1970: L-Dopa in Parkinson's-syndrome. new therapeutic attack?. Therapie der Gegenwart 109(11): 1590-1593
Bugiani, O.; Gatti, R. 1980: L-Dopa in children with progressive neurological disorders. Annals of Neurology 7(1): 93
Henry, P. 1970: L-Dopa in parkinsonism, myth or reality. Bordeaux Medical 3(2): 393-397
Mena, I.; Court, J.; Fuenzalida, S.; Papavasiliou, P.S.; Cotzias, G.C. 1969: L-Dopa in the management of chronic manganese poisoning. Revista Medica de Chile 97(6): 343-351
Warot, P. 1971: L-Dopa in the treatment of Parkinson's disease. Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 17(Suppl): 329-334
Mazza, C.; Buffatti, P.F.; Bazzan, A.; Lion, P. 1970: L-Dopa in the treatment of Parkinson's disease. (Considerations on 51 cases). Il Fracastoro 63(5): 768-773
Mano, T. 1973: L-Dopa induced dyskinesia--electromyographic approaches. Rinsho Shinkeigaku 13(6): 385-395
Cooper, D.R.; Marrel, C.; Testa, B.; van de Waterbeemd, H.; Quinn, N.; Jenner, P.; Marsden, C.D. 1984: L-Dopa methyl ester--a candidate for chronic systemic delivery of L-Dopa in Parkinson's disease. Clinical Neuropharmacology 7(1): 89-98
Greer, M. 1970: L-Dopa therapy in Parkinson's disease. Journal of the Florida Medical Association 57(6): 23-27
Fincham, R.W.; Decker, D.A. 1970: L-Dopa therapy in Parkinson's disease (a year's experience with 20 patients). Journal of the Iowa Medical Society 60(11): 755-759
Worm-Petersen, J.; Dupont, E.; Mikkelsen, B. 1971: L-Dopa therapy in Parkinson's disease. a double-blind study. Ugeskrift for Laeger 133(47): 2321-2326
Gutmann, L.; Martin, J.D.; Gutrecht, J.A. 1970: L-Dopa therapy of Parkinson's disease. (A review of the preliminary experience at West Virginia University). West Virginia Medical Journal 66(4): 109-111
Anda, J.A. 1971: L-Dopa therapy of parkinsonism. Nordisk Medicin 85(2): 63-64
Poeck, K. 1971: L-Dopa therapy of the Parkinson syndrome. Deutsche Medizinische Wochenschrift 71(10): 436
Rinne, U.K.; Sonninen, V.; Siirtola, T. 1970: L-Dopa treatment in Parkinson's Disease. European Neurology 4(6): 348-369
Klawans, H.L.; Ringel, S.P. 1973: L-Dopa, B 6 , and alpha-methyldopa hydrazine. Confinia Neurologica 35(3): 186-192
Rees, E. 1972: L-Dopa--a remarkable response. Nursing Mirror and Midwives Journal 134(5): 26-27
Kissel, P.; Tridon, P.; Masingue, M.; Andre, J.M. 1972: L-Dopa-Propranolol association and parkinsonian trembling. La Nouvelle Presse Medicale 1(29): 1943
Ng, K.Y.; Chase, T.N.; Colburn, R.W.; Kopin, I.J. 1970: L-Dopa-induced release of cerebral monoamines. Science 170(3953): 76-77
Mendelsohn, N.; Michl, J.; Gilbert, H.S.; Acs, G.; Christman, J.K. 1980: L-Ethionine as an inducer of differentiation in human promyelocytic leukemia cells (HL-60). Cancer Research 40(9): 3206-3210
McCann, B.C. 1969: Post-stroke rehabilitation. Rhode Island Medical Journal 52(1): 23-31 Passim
Feingold, D.S. 1969: L-Forms: their biology and role in disease. Medical Times 97(1): 106-111
Yuen, R.; Schachter, H. 1972: L-Fucose metabolism in mammals. I. Port liver L-fuconate hydro-lyase. Canadian Journal of Biochemistry 50(7): 798-806
Shepherd, V.L.; Lee, Y.C.; Schlesinger, P.H.; Stahl, P.D. 1981: L-Fucose-terminated glycoconjugates are recognized by pinocytosis receptors on macrophages. Proceedings of the National Academy of Sciences of the United States of America 78(2): 1019-1022
Fisher, H.F. 1985: L-Glutamate dehydrogenase from bovine liver. Methods in Enzymology 113: 16-27
Chang, H.H.; Michaelis, E.K. 1982: L-Glutamate effects on electrical potentials of synaptic plasma membrane vesicles. Biochimica et Biophysica Acta 688(2): 285-294
Gray, P.N.; May, P.C.; Mundy, L.; Elkins, J. 1980: L-Glutamate toxicity in Huntington's disease fibroblasts. Biochemical and Biophysical Research Communications 95(2): 707-714
Cooper, A.J. 1985: L-Glutamate-L-amino acid transaminases. Methods in Enzymology 113: 63-65
Scandurra, R.; Cannella, C.; Ferretti, M.G. 1967: L-Glutamate-phenylpyruvate amintransferase. 1. Purification of the enzyme. European Journal of Biochemistry 3(2): 219-223
Gore, M.G. 1981: L-Glutamic acid dehydrogenase. International Journal of Biochemistry 13(8): 879-886
Mazlen, R.G.; Muellenberg, C.G.; O'Brien, P.J. 1970: L-Glutamine D-fructose 6-phosphate amidotransferase from bovine retina. Experimental Eye Research 9(1): 1-11
Mebane, A.H. 1984: L-Glutamine and mania. American Journal of Psychiatry 141(10): 1302-1303
Besagni, D.; Minn, A.; Gayet, J. 1981: L-Glutamine transport into synaptosomes isolated from rat brain. Comptes Rendus des Seances de l'Academie des Sciences. Serie Iii Sciences de la Vie 293(1): 85-88
Koizumi, M. 1965: L-Glutamine-oxalo-acetic acid transaminase in human and rabbit placental villi. Nihon Sanka Fujinka Gakkai Zasshi 17(5): 423-431
Chalmers, R.A.; Tracey, B.M.; Mistry, J.; Griffiths, K.D.; Green, A.; Winterborn, M.H. 1984: L-Glyceric aciduria (primary hyperoxaluria type 2) in siblings in two unrelated families. Journal of Inherited Metabolic Disease 7(Suppl 2): 133-134
Lee, Y.P.; Choy, P.C. 1974: L-Glycerol 3-phosphate dehydrogenases. 3. Studies on the immunological differences of nicotinamide adenine dinucleotide-linked L-glycerol 3-phosphate dehydrogenase in various organs of the rat and rabbit. Journal of Biological Chemistry 249(2): 476-481
Lee, Y.P.; Craine, J.E.; Lee, A.S. 1973: L-Glycerol 3-phosphate dehydrogenases. II. Effects of phosphorylated compounds on nicotinamide adenine dinucleotide linked enzyme from rabbit liver. Journal of Biological Chemistry 248(16): 5610-5615
Burgos, J.; Sarmiento, R.M. 1982: L-Glycol dehydrogenase from hen muscle. Methods in Enzymology 89 Pt D: 523-526
Barbin, G.; Palacios, J.M.; Garbarg, M.; Schwartz, J.C.; Gaspar, P.; Javoy-Agid, F.; Agid, Y. 1980: L-Histidine decarboxylase in the human brain: properties and localization. Journal of Neurochemistry 35(2): 400-406
Lin, C.W.; Fishman, W.H. 1972: L-Homoarginine. An organ-specific, uncompetitive inhibitor of human liver and bone alkaline phosphohydrolases. Journal of Biological Chemistry 247(10): 3082-3087
Kakizoe, T.; Nishio, Y.; Honma, Y.; Niijima, T.; Sugimura, T. 1983: L-Isoleucine and L-leucine are promoters of bladder cancer in rats. Princess Takamatsu Symposia 14: 373-380
Kay, M.M. 1971: L-Isoleucine: an inducer of the feeding response in decapod crustaceans. Experientia 27(1): 103-104
Leichtweiss, H.P.; Schröder, H. 1981: L-Lactate and D-Lactate carriers on the fetal and the maternal side of the trophoblast in the isolated guinea pig placenta. Pflugers Archiv: European Journal of Physiology 390(1): 80-85
Taguchi, H.; Matsuzawa, H.; Ohta, T. 1984: L-Lactate dehydrogenase from Thermus caldophilus GK24, an extremely thermophilic bacterium. Desensitization to fructose 1,6-bisphosphate in the activated state by arginine-specific chemical modification and the N-terminal amino acid sequence. European Journal of Biochemistry 145(2): 283-290
Hillier, A.J.; Jago, G.R. 1982: L-Lactate dehydrogenase, FDP-activated, from Streptococcus cremoris. Methods in Enzymology 89 Pt D: 362-367
Frick, G.P.; Tai, L.R.; Blinder, L.; Goodman, H.M. 1981: L-Leucine activates branched chain alpha-keto acid dehydrogenase in rat adipose tissue. Journal of Biological Chemistry 256(6): 2618-2620
Rosenberg, R. 1981: L-Leucine transport in human red blood cells: a detailed kinetic analysis. Journal of Membrane Biology 62(1-2): 79-93
Tanizawa, K.; Yoshimura, T.; Soda, K. 1985: L-Lysine transaminase from Flavobacterium lutescens. Methods in Enzymology 113: 96-102
Yagi, T.; Misono, H.; Kurihara, N.; Yamamoto, T.; Soda, K. 1980: L-Lysine: 2-oxoglutarate 6-aminotransferase. Subunit structure composed of non-identical polypeptides and pyridoxal 5'-phosphate-binding subunit. Journal of Biochemistry 87(5): 1395-1402
Soda, K.; Misono, H.; Yamamoto, T. 1968: L-Lysine:alpha-ketoglutarate aminotransferase. I. Identification of a product, delta-1-piperideine-6-carboxylic acid. Biochemistry 7(11): 4102-4109
Soda, K.; Misono, H. 1968: L-Lysine:alpha-ketoglutarate aminotransferase. II. Purification, crystallization, and properties. Biochemistry 7(11): 4110-4119
Miller, E.S.; Brenchley, J.E. 1981: L-Methionine SR-sulfoximine-resistant glutamine synthetase from mutants of Salmonella typhimurium. Journal of Biological Chemistry 256(21): 11307-11312
Meininger, V.; Flamier, A.; Phan, T.; Ferris, O.; Uzan, A.; Lefur, G. 1982: L-Methionine treatment of Parkinson's disease: preliminary results. Revue Neurologique (Paris) 138(4): 297-303
Babbedge, R.C.; Wallace, P.; Gaffen, Z.A.; Hart, S.L.; Moore, P.K. 1993: L-NG-nitro arginine p-nitroanilide (L-NAPNA) is anti-nociceptive in the mouse. Neuroreport 4(3): 307-310
Shigeura, H.T.; Hen, A.C.; Hiremath, C.B.; Maag, T.A. 1969: L-O-Ethylthreonine--an antagonist of L-isoleucine. Archives of Biochemistry and Biophysics 135(1): 90-96
Fozard, J.R.; Part, M.L.; Prakash, N.J.; Grove, J.; Schechter, P.J.; Sjoerdsma, A.; Koch-Weser, J. 1980: L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis. Science 208(4443): 505-508
Janssen, A.J.; Plakké, T.; Trijbels, F.J.; Sengers, R.C.; Monnens, L.A. 1981: L-Ornithine ketoacid-transaminase assay in hair roots of homozygotes and heterozygotes for gyrate atrophy. Clinica Chimica Acta; International Journal of Clinical Chemistry 113(2): 213-216
Marsh, H.V.; Havir, E.A.; Hanson, K.R. 1968: L-Phenylalanine ammonia-lyase. 3. Properties of the enzyme from maize seedlings. Biochemistry 7(5): 1915-1918
Chládek, S.; Ringer, D.; Zemlicka, J. 1973: L-Phenylalanine esters of open-chain analog of adenosine as substrates for ribosomal peptidyl transferase. Biochemistry 12(25): 5135-5138
Komoda, T.; Hokari, S.; Sonoda, M.; Sakagishi, Y.; Tamura, T. 1982: L-Phenylalanine inhibition of human alkaline phosphatases with p-nitrophenyl phosphate as substrate. Clinical Chemistry 28(12): 2426-2428
Palmer, T.N.; Odedra, B.R. 1982: L-Phenylalanine inhibition of muscle pyruvate kinase. Bioscience Reports 2(10): 825-833
Porter, D.H.; Cardenas, J.M. 1980: L-Phenylalanine stereospecifically inhibits the renaturation of muscle pyruvate kinase. Archives of Biochemistry and Biophysics 202(1): 54-62
Garweg, G.; von Rehren, D.; Hintze, U. 1980: L-Pipecolate formation in the mammalian brain. Regional distribution of delta1-pyrroline-2-carboxylate reductase activity. Journal of Neurochemistry 35(3): 616-621
Garweg, G.; Kinsky, I. 1970: L-Proline and L-histidine in the autoradiogram of the mouse subcommissural organ. Die Naturwissenschaften 57(5): 253
Keller, E.; Davis, J.L.; Tachiki, K.H.; Cummins, J.T.; Baxter, C.F. 1981: L-Proline inhibition of glutamate release. Journal of Neurochemistry 37(5): 1335-1337
Hwang, S.M.; Serabian, M.A.; Roth, K.S.; Segal, S. 1983: L-Proline transport by isolated renal tubules from newborn and adult rats. Pediatric Research 17(1): 42-46
Horák, J.; Ríhová, L. 1982: L-Proline transport in Saccharomyces cerevisiae. Biochimica et Biophysica Acta 691(1): 144-150
Filippova IYu; Lysogorskaya, E.N.; Oksenoit, E.S.; Rudenskaya, G.N.; Stepanov, V.M. 1984: L-Pyroglutamyl-L-phenylalanyl-L-leucine-p-nitroanilide--a chromogenic substrate for thiol proteinase assay. Analytical Biochemistry 143(2): 293-297
Kramps, J.A.; van Twisk, C.; van der Linden, A.C. 1983: L-Pyroglutamyl-L-prolyl-L-valine-p-nitroanilide, a highly specific substrate for granulocyte elastase. Scandinavian Journal of Clinical and Laboratory Investigation 43(5): 427-432
Schwartz, N.B.; Abram, D.; Feingold, D.S. 1974: L-Rhamnulose 1-phosphate aldolase of Escherichia coli. the role of metal in enzyme structure. Biochemistry 13(8): 1726-1730
Gielow, W.O.; Lee, N.L. 1974: L-Ribulokinase from an initiator constitutive mutant. Journal of Bacteriology 120(1): 539-541
Deupree, J.D.; Wood, W.A. 1972: L-Ribulose 5-phosphate 4-epimerase from Aerobacter aerogenes. Evidence for a role of divalent metal ions in the epimerization reaction. Journal of Biological Chemistry 247(10): 3093-3097
Hobbins, J.C.; Brock, W.; Speroff, L.; Anderson, G.G.; Caldwell, B. 1972: L-S ratio in predicting pulmonary maturity in utero. Obstetrics and Gynecology 39(5): 660-664
Cosloy, S.D.; McFall, E. 1970: L-Serine-sensitive mutants of Escherichia coli K-12. Journal of Bacteriology 103(3): 840-841
Slater, A.C.; Jones-Mortimer, M.C.; Kornberg, H.L. 1981: L-Sorbose phosphorylation in Escherichia coli K-12. Biochimica et Biophysica Acta 646(2): 365-367
Anderson, R.L.; Simkins, R.A. 1982: L-Sorbose-1-phosphate reductase. Methods in Enzymology 89 Pt D: 248-251
Willetts, A.J.; Turner, J.M. 1971: L-Threonine acetaldehyde-lyase in a strain of Bacillus subtilis. Biochimica et Biophysica Acta 252(1): 105-110
Kagan, Z.S.; Sinel'nikova, E.M.; Kretovich, V.L. 1969: L-Threonine dehydratases of flowering parasitic and saprophytic plants. Biokhimiia 34(3): 564-576
Aoyama, Y.; Motokawa, Y. 1981: L-Threonine dehydrogenase of chicken liver. Purification, characterization, and physiological significance. Journal of Biological Chemistry 256(23): 12367-12373
Cooper, D.S.; Halpern, R.; Wood, L.C.; Levin, A.A.; Ridgway, E.C. 1984: L-Thyroxine therapy in subclinical hypothyroidism. a double-blind, placebo-controlled trial. Annals of Internal Medicine 101(1): 18-24
Kumegawa, M.; Maeda, N.; Yajima, T.; Takuma, T.; Ikeda, E.; Minamide, C. 1980: L-Thyroxine, cortisol and diet affect the level of amylase in the parotid gland of developing rats. Journal of Endocrinology 87(1): 65-71
Soffer, R.L.; Hechtman, P.; Savage, M. 1973: L-Triiodothyronine aminotransferase. Journal of Biological Chemistry 248(4): 1224-1230
Willard, P.W. 1969: L-Triiodothyronine and dinitrophenol-induced hypertension. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 132(1): 181-187
Brown, D.R.; Growdon, J.H. 1980: L-Tryptophan administration potentiates serotonin-dependent myoclonic behavior in the rat. Neuropharmacology 19(4): 343-347
Aghajanian, G.K.; Haigler, H.J. 1974: L-Tryptophan as a selective histochemical marker for serotonergic neurons in single-cell recording studies. Brain Research 81(2): 364-372
Beitman, B.D.; Dunner, D.L. 1982: L-Tryptophan in the maintenance treatment of bipolar Ii manic-depressive illness. American Journal of Psychiatry 139(11): 1498-1499
Arnold, M.A.; Fernstrom, J.D. 1981: L-Tryptophan injection enhances pulsatile growth hormone secretion in the rat. Endocrinology 108(1): 331-335
Rosenberg, R.; Young, J.D.; Ellory, J.C. 1980: L-Tryptophan transport in human red blood cells. Biochimica et Biophysica Acta 598(2): 375-384
Radulovacki, M. 1982: L-Tryptophan's effects on brain chemistry and sleep in cats and rats: a review. Neuroscience and Biobehavioral Reviews 6(4): 421-427
Gibbons, J.L.; Barr, G.A.; Bridger, W.H.; Leibowitz, S.F. 1981: L-Tryptophan's effects on mouse killing, feeding, drinking, locomotion, and brain serotonin. Pharmacology Biochemistry and Behavior 15(2): 201-206
Hartmann, E.; Chung, R.; Chien, C.P. 1971: L-Tryptophane and sleep. Psychopharmacologia 19(2): 114-127
Fuller, R.W.; Snoddy, H.D. 1982: L-Tyrosine enhancement of the elevation of 3,4-dihydroxyphenylacetic acid concentration in rat brain by spiperone and amfonelic acid. Journal of Pharmacy and Pharmacology 34(2): 117-118
Barrio, J.R.; Keen, R.E.; Ropchan, J.R.; MacDonald, N.S.; Baumgartner, F.J.; Padgett, H.C.; Phelps, M.E. 1983: L-[1-11C]leucine: routine synthesis by enzymatic resolution. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 24(6): 515-521
Werling, L.L.; Doman, K.A.; Nadler, J.V. 1983: L-[3H]Glutamate binding to hippocampal synaptic membranes: two binding sites discriminated by their differing affinities for quisqualate. Journal of Neurochemistry 41(2): 586-593
Barrio, J.R.; Egbert, J.E.; Henze, E.; Schelbert, H.R.; Baumgartner, F.J. 1982: L-[4-11C]aspartic acid: enzymatic synthesis, myocardial uptake, and metabolism. Journal of Medicinal Chemistry 25(1): 93-96
Váli, Z.; Kilár, F.; Lakatos, S.; Venyaminov, S.A.; Závodszky, P. 1980: L-alanine dehydrogenase from Thermus thermophilus. Biochimica et Biophysica Acta 615(1): 34-47
Vijayvargiya, R.; Singhal, R.L.; Ling, G.M. 1969: L-alanine: an activator of pyruvate kinase in the rat prostate. Life Sciences 8(18): 1001-1008
James, R.C.; Freeman, R.W.; Harbison, R.D. 1984: L-alpha-acetylmethadol-induced tissue alterations in mice. Drug and Chemical Toxicology 7(1): 91-112
Yamada, M.; Terada, T. 1974: L-alpha-glycerol 3-phosphate as an oxidative substrate for cock spermatozoa. American Journal of Physiology 227(3): 729-733
Levy, M.R.; Hunt, A.E. 1967: L-alpha-hydroxy acid oxidase activity in Tetrahymena. Change with physiological state. Journal of Cell Biology 34(3): 911-915
Alestig, K.; Sannerstedt, R. 1966: L-alpha-methyl-dopa versus the racemic form--a comparative study of the hypotensive effect. Acta Medica Scandinavica 179(6): 747-753
Glasgow, G.L.; Henley, J.W.; Willoughby, E.W. 1974: L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. Australian and New Zealand Journal of Medicine 4(4): 373-378
Nitta, Y.; Yasuda, Y.; Tochikubo, K.; Hachisuka, Y. 1974: L-amino acid dehydrogenases in Bacillus subtilis spores. Journal of Bacteriology 117(2): 588-592
Shaham, N.; Bdolah, A. 1973: L-amino acid oxidase from Vipera palaestinae venom: purification and assay. Comparative Biochemistry and Physiology. B Comparative Biochemistry 46(4): 691-698
Bonilla, C.A.; Faith, M.R.; Minton, S.A. 1973: L-amino acid oxidase, phosphodiesterase, total protein and other properties of juvenile timber rattlesnake (C. H. horridus) venom at different stages of growth. Toxicon: Official Journal of the International Society on Toxinology 11(3): 301-303
Page, D.S.; Vanetten, R.L. 1971: L-amino acid oxidase. II. Deuterium isotope effects and the action mechanism for the reduction of L-amino acid oxidase by L-leucine. Biochimica et Biophysica Acta 227(1): 16-31
Pelmont, J.; Arlaud, G.; Rossat, A.M. 1972: L-amino acid oxidases of Proteus mirabilis: general properties. Biochimie 54(10): 1359-1374
Wandrey, C.; Fiolitakis, E.; Wichmann, U.; Kula, M.R. 1984: L-amino acids from a racemic mixture of alpha-hydroxy acids. Annals of the new York Academy of Sciences 434: 91-94
Page, D.S.; Van Etten, R.L. 1969: L-amino-acid oxidase. I. Effect of pH. Biochimica et Biophysica Acta 191(1): 38-45
Hogg, R.W.; Englesberg, E. 1969: L-arabinose binding protein from Escherichia coli B-r. Journal of Bacteriology 100(1): 423-432
Pauley, J.; Power, J.; Irr, J. 1972: L-arabinose isomerase formation in a conditional mutant of gene araA of Escherichia coli B-r. Journal of Bacteriology 112(3): 1247-1253
Schleif, R.F. 1971: L-arabinose operon messenger of Escherichia coli. Its inducibility and translation efficiency relative to lactose operon messenger. Journal of Molecular Biology 61(1): 275-279
Kolodrubetz, D.; Schleif, R. 1981: L-arabinose transport systems in Escherichia coli K-12. Journal of Bacteriology 148(2): 472-479
Cotton, E.K.; Solomons, C.C.; Dubois, R. 1973: L-arginine and cystic fibrosis. Pediatrics 51(3): 586-588
Scibona, M.; Meschini, P.; Capparelli, S.; Pecori, C.; Rossi, P.; Menchini Fabris, G.F. 1994: L-arginine and male infertility. Minerva Urologica e Nefrologica 46(4): 251-253
Garcia, N.M.; Horton, J.W. 1994: L-arginine improves resting cardiac transmembrane potential after burn injury. Shock 1(5): 354-358
Servino, V.; Nuti, M. 1968: L-arginine in the diagnosis and symptomatological therapy of malignant tumors of the pancreas. Minerva Medica 59(26): 1504
Silbernagl, S.; Deetjen, P. 1972: L-arginine transport in rat proximal tubules. Microperfusion studies on reabsorption kinetics. Pflugers Archiv: European Journal of Physiology 336(1): 79-86
Khramov, V.A.; Farber, S.M.; Kharats, K.S. 1973: L-arginine, L-histidine and L-lysine utilization by Escherichia coli. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 50(1): 119-121
Solomons, C.; Hathaway, W.; Cotton, E. 1972: L-arginine, the sickling phenomenon, and cystic fibrosis. Pediatrics 49(6): 933
Gniot-Szulzycka, J. 1982: L-ascorbic acid 2-sulphate. Postepy Biochemii 28(1-2): 137-143
Neshyba, P.; Louzenský, G. 1981: L-ascorbic acid and its effect on oxalic acid excretion in the urine. Casopis Lekaru Ceskych 120(31-32): 937-940
Baig, M.M.; Kelly, S.; Loewus, F. 1970: L-ascorbic acid biosynthesis in higher plants from L-gulono-1, 4-lactone and L-galactono-1, 4-lactone. Plant Physiology 46(2): 277-280
Klinger, W.; Ankermann, H. 1965: L-ascorbic acid concentration in the the organs of rats of various age and sex before and after treatment with barbital. Acta Biologica et Medica Germanica 14(6): 764-773
Bleeg, H.S. 1966: L-ascorbic acid in yeast and isolation of L-galactono-gamma-lactone oxidase from the mitochondria. Enzymologia 31(2): 105-112
Chou, P.T.; Khan, A.U. 1983: L-ascorbic acid quenching of singlet delta molecular oxygen in aqueous media: generalized antioxidant property of vitamin C. Biochemical and Biophysical Research Communications 115(3): 932-937
Hatanaka, H.; Ogawa, Y.; Egami, F. 1974: L-ascorbic acid sulfate esters with special reference to enzymatic hydrolysis. Journal of Biochemistry 75(4): 861-866
Struhár, M.; Fecák, B.; Mandák, M. 1968: L-ascorbic acid--brief review of stability and stabilization of aqueous solutions. Ceskoslovenska Farmacie 17(6): 306-311
Giani, G.; Nicolin, A. 1969: L-asparaginase. Archivio Italiano di Patologia E Clinica Dei Tumori 12(3): 189-204
Capizzi, R.L.; Bertino, J.R.; Handschumacher, R.E. 1970: L-asparaginase. Annual Review of Medicine 21: 433-444
Leventhal, B.G.; Skeel, R.T.; Yankee, R.A.; Henderson, E.S. 1970: L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia. Cancer ChemoTherapy Reports 54(1): 47-51
Glossmann, H.; Bode, W. 1971: L-asparaginase a from Escherichia coli. the molecular weight of the subunit and the demonstration of an intramolecular disulfide bridge. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 352(2): 132-136
Ehrman, M.; Cedar, H.; Schwartz, J.H. 1971: L-asparaginase Ii of Escherichia coli. Studies on the enzymatic mechanism of action. Journal of Biological Chemistry 246(1): 88-94
Mostafa, S.A.; Ali, O.K. 1983: L-asparaginase activity in cell-free extracts of Thermoactinomyces vulgaris 13 M.E.S. Zentralblatt für Mikrobiologie 138(5): 397-404
Sharma, S.C.; Jayaram, H.N.; Ramakrishnan, T. 1973: L-asparaginase activity in mycobacteria. American Review of Respiratory Disease 108(3): 688-689
Schwartz, M.K.; Lash, E.D.; Oettgen, H.F.; Tomato, F.A. 1970: L-asparaginase activity in plasma and other biological fluids. Cancer 25(2): 244-252
Canellos, G.P.; Carbone, P.P.; Ziegler, Z.I. 1969: L-asparaginase and Burkitt's lymphoma. Lancet 2(7616): 380
Cooney, D.A.; Handschumacher, R.E. 1970: L-asparaginase and L-asparagine metabolism. Annual Review of Pharmacology 10: 421-440
Desser, H. 1973: L-asparaginase and L-glutaminase activities in leukocytes and plasma in polycythemia vera. Blut 27(1): 54-58
St Pierre, R.L.; Tennenbaum, J.I.; Folk, R.M. 1970: L-asparaginase and allograft immunity. Lancet 2(7687): 1365-1366
Kahn, J.M.; Fidler, I.J. 1973: L-asparaginase and alteration of lymphocyte surface. Inhibition of the rat mixed leukocyte interaction. Journal of Medicine 4(4): 248-256
Astaldi, G.; Burgio, G.R.; Krc, J.; Genova, R.; Astaldi, A.A. 1969: L-asparaginase and blastogenesis. Lancet 1(7591): 423
Burgio, G.R.; Vaccaro, R.; Gasparoni, M.C.; Astaldi, A. 1970: L-asparaginase and immunoglobulins. Lancet 2(7687): 1364-1365
Han, T.; Onuma, T. 1974: L-asparaginase and in vitro lymphocyte blastogenesis. Cell membrane alteration as possible mechanism of inhibitory effect. Immunology 26(1): 169-173
Burgio, G.R.; Astaldi, A.; Astaldi, G.; Krc, I.; Micu, D. 1970: L-asparaginase and inhibition of the lymphocyte immune reaction. Il Farmaco; Edizione Scientifica 25(2): 85-95
Grundmann, E. 1969: L-asparaginase and leukemia. Klinische Wochenschrift 47(2): 61-64
Halikowski, B.; Garwicz, S.; Armata, J. 1969: L-asparaginase and low-protein diet in acute leukaemia. Lancet 1(7591): 423-424
Fidler, I.J.; Montgomery, P.C.; Ferguson, E. 1971: L-asparaginase and lymphocyte blastogenesis. Lancet 2(7733): 1091-1092
Fidler, I.J. 1970: L-asparaginase and metastasis. Lancet 1(7650): 777-778
Shaw, M.T.; Barnes, C.C.; Madden, F.J.; Bagshawe, K.D. 1970: L-asparaginase and pancreatitis. Lancet 2(7675): 721
Rodriguez, A.R. 1980: L-asparaginase and toxic epidermal necrolysis. Journal of the Medical Association of Georgia 69(5): 355; 357
Mirecka, J.; Astaldi, G.; Szmigiel, Z.; Lisiewicz, J.; Wazewska-Czyzewska, M. 1972: L-asparaginase effect on the erythrocyte-immunoglobulin binding in acquired hemolytic anemia. Acta Haematologica 47(2): 71-80
Kessel, D.; Bosmann, H.B. 1972: L-asparaginase effects on intact murine leukemia cells and on isolated cell plasma membranes. Biochemical and Biophysical Research Communications 48(1): 35-40
McCredie, K.B.; Ho, D.H.; Freireich, E.J. 1973: L-asparaginase for the treatment of cancer. Ca: a Cancer Journal for Clinicians 23(4): 220-227
Shniak, E.I.; Rubashenko, V.P. 1974: L-asparaginase formation by several strains of Proteus vulgaris. Prikladnaia Biokhimiia i Mikrobiologiia 10(5): 713-716
Howard, J.B.; Carpenter, F.H. 1972: L-asparaginase from Erwinia carotovora. Substrate specificity and enzymatic properties. Journal of Biological Chemistry 247(4): 1020-1030
Shifrin, S.; Solis, B.G. 1972: L-asparaginase from Escherichia coli B. Chemical modifications of tyrosyl residues. Journal of Biological Chemistry 247(13): 4121-4125
Tosa, T.; Sano, R.; Yamamoto, K.; Nakamura, M.; Chibata, I. 1972: L-asparaginase from Proteus vulgaris. Purification, crystallization, and enzymic properties. Biochemistry 11(2): 217-222
Japa, J.; Kardaszewicz, E.; Kowalski, S. 1972: L-asparaginase in acute leukemia refractory to treatment. Polskie Archiwum Medycyny Wewnetrznej 48(6): 627-631
Armata, J.; Wyszkowski, J.; Cyklis, R.; Zajaczkowski, J.; Depowska, T. 1971: L-asparaginase in advanced acute leukemia in children. Polski Tygodnik Lekarski 26(22): 826-828
Georgiev, Z.; Genova, V.; Avramova, D. 1973: L-asparaginase in blast leukemia. Vutreshni Bolesti 12(6): 25-37
Anonymous 1970: L-asparaginase in cancer therapy. Nutrition Reviews 28(8): 206-209
Cyklis, R.; Armata, J.; Legutko, L. 1974: L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow. Acta Haematologica Polonica 5(3): 201-206
Legutko, L.; Armata, J.; Zajackowski, J.; Cyklis, R.; Halikowska-Lacka, E. 1974: L-asparaginase in combined treatment of lymphosarcoma in children. Polski Tygodnik Lekarski 29(52): 2267-2269
Khan, A.; Hill, J.M.; Adachi, M. 1970: L-asparaginase in experimental auto-immune disease: inhibition of allergic encephalomyelitis. Journal of Immunology 105(1): 256-258
Böttiger, L.E. 1967: L-asparaginase in leukemia. Nordisk Medicin 78(46): 1521
Colebatch, J.H. 1971: L-asparaginase in malignant disease. Australian and New Zealand Journal of Medicine 1(1): 96-98
Armata, J.; Halikowski, B.; Wyszkowski, J. 1970: L-asparaginase in the 12th relapse of acute lympoblastic leukemia in a child. Pediatria Polska 45(8): 971-976
Massimo, L.; Fossati-Guglielmoni, A.; Mori, P.G.; Cottafava, F.; Costa-del Brenna, A.; Dagna-Bricarelli, F. 1970: L-asparaginase in the therapy of acute lymphoblastic leukemia in children. Haematologica 55(9): 603-608
Rokicka-Milewska, R.; Derulska, D.; Kwiatkowska-Patzer, B. 1974: L-asparaginase in the treatment of acute leukemia in children. Pediatria Polska 49(8): 979-990
Butoianu, E.; Nicoară, S.T.; Broşteanu, R.; Coliţă, A.; Coliţă, D. 1971: L-asparaginase in the treatment of acute leukemias. Medicina Interna 23(5): 611-620
Astaldi, G. 1970: L-asparaginase in the treatment of acute leukemias. Biological aspects. Il Cancro 23(3): 139-145
Storti, E.; Fontana, G.; Ascari, E.; Lusvarghi, E.; Silingardi, V.; Quaglino, D.; Sgandurra, A.; Barbieri, U.; Traldi, A. 1970: L-asparaginase in the treatment of acute leukoses. Minerva Medica 61(71): 3635-3642
Bohlmann, H.G.; Gallmeier, W.M.; Göbel, F.J.; Stier, H.W. 1969: L-asparaginase in the treatment of lymphoblastic leukemia in children. Zeitschrift für Kinderheilkunde 107(2): 107-114
Jaffe, N.; Traggis, D.; Das, L.; Moloney, W.C.; Hann, H.W.; Kim, B.S.; Nair, R. 1971: L-asparaginase in the treatment of neoplastic diseases in children. Cancer Research 31(7): 942-949
Hardy, W.D.; Old, L.J. 1970: L-asparaginase in the treatment of neoplastic diseases of the dog, cat and cow. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 33: 131-139
Astaldi, G. 1971: L-asparaginase in the treatment of the acute leukemias. Biological aspects. Sangre 16(1): 1-6
Beard, M.E.; Crowther, D.; Galton, D.A.; Guyer, R.J.; Fairley, G.H.; Kay, H.E.; Knapton, P.J.; Malpas, J.S.; Scott, R.B. 1970: L-asparaginase in treatment of acute leukaemia and lymphosarcoma. British Medical Journal 1(5690): 191-195
Capizzi, R.L.; Summers, W.P.; Bertino, J.R. 1971: L-asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y. Annals of the new York Academy of Sciences 186: 302-311
Bauer, K.A.; Teitel, J.M.; Rosenberg, R.D. 1983: L-asparaginase induced antithrombin IIi deficiency: evidence against the production of a hypercoagulable state. Thrombosis Research 29(4): 437-442
Friedman, H. 1971: L-asparaginase induced immunosuppression: inhibition of bone marrow derived antibody precursor cells. Science 174(4005): 139-141
Barbui, T.; Finazzi, G.; Viganò, S.; Mannucci, P.M. 1984: L-asparaginase lowers protein C antigen. Thrombosis and Haemostasis 52(2): 216
Plaquet, R.; Rogez, J.C.; Biserte, G. 1971: L-asparaginase of guinea-pig liver: demonstration and separation of 2 enzymatic activities; study of their physicochemical characteristics. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences. Serie D: Sciences Naturelles 273(12): 1051-1053
Riccardi, R.; Holcenberg, J.S.; Glaubiger, D.L.; Wood, J.H.; Poplack, D.G. 1981: L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans. Cancer Research 41(11 Part 1): 4554-4558
Peterson, R.E.; Ciegler, A. 1969: L-asparaginase production by Erwinia aroideae. Applied Microbiology 18(1): 64-67
Peterson, R.E.; Ciegler, A. 1969: L-asparaginase production by various bacteria. Applied Microbiology 17(6): 929-930
Kaczurba, E. 1971: L-asparaginase production by various species of Salmonella. Acta Microbiologica Polonica. Series B: Microbiologia Applicata 3(3): 135-142
Pajdak, E. 1971: L-asparaginase production by various strains of gram-negative bacteria. Medycyna Doswiadczalna i Mikrobiologia 23(3): 211-216
Boeck, L.D.; Ho, P.P. 1973: L-asparaginase production during static incubation of aerobically grown Escherichia coli B. Canadian Journal of Microbiology 19(10): 1251-1257
Kondrat'eva, N.A.; Kruglova, G.V.; Lorie, I.I.; Koshel', I.V.; Kurmashov, V.I. 1980: L-asparaginase study results (phase Ii of the clinical trials). Antibiotiki 25(9): 686-689
Robison, R.S.; Berk, B. 1969: L-asparaginase synthesis by Escherichia coli B. Biotechnology and Bioengineering 11(6): 1211-1225
Hill, J.M.; Roberts, J.; Loeb, E.; Khan, A.; MacLellan, A.; Hill, R.W. 1967: L-asparaginase therapy for leukemia and other malignant neoplasms. Remission in human leukemia. JAMA 202(9): 882-888
Massolo, F.; Galli, V. 1971: L-asparaginase therapy in 14 cases of acute lymphatic leukemia observed at the Clinica Pediatrica di Modena. Minerva Pediatrica 23(35): 1411-1413
Sutow, W.W.; Garcia, F.; Starling, K.A.; Williams, T.E.; Lane, D.M.; Gehan, E.A. 1971: L-asparaginase therapy in children with advanced leukemia. the Southwest Cancer Chemotherapy Study Group. Cancer 28(4): 819-824
Anonymous 1970: L-asparaginase therapy in leukemia. Postgraduate Medicine 48(3): 265-268
Haskell, C.M.; Canellos, G.P.; Leventhal, B.G.; Carbone, P.P.; Serpick, A.A.; Hansen, H.H. 1969: L-asparaginase toxicity. Cancer Research 29(4): 974-975
Suvatte, V.; Tuchinda, S. 1973: L-asparaginase treatment in acute leukemia of childhood. Journal of the Medical Association of Thailand 56(11): 634-644
De Vaan, G.A.; Bakkeren, J.A.; Schretlen, E.D.; Reerink, H. 1971: L-asparaginase treatment of acute leukaemia in children. Acta Paediatrica Scandinavica 60(1): 22-26
Hansen, H.H.; Canellos, G.P. 1970: L-asparaginase treatment of acute myeloblastic leukemia. Oncology 24(5): 349-357
Horvath, C.; Sardi, A.; Woods, J.S. 1973: L-asparaginase tubes: kinetic behavior and application in physiological studies. Journal of Applied Physiology 34(2): 181-187
Hernádi, F. 1969: L-asparaginase, a new drug of antileukemic action. Orvosi Hetilap 110(4): 187-189
Bordigoni, P.; Briquel, E.; Olive, D. 1981: L-asparaginase, antithrombin IIi deficiency and thromboses. Archives Francaises de Pediatrie 38(9): 653-655
Conard, J.; Cazenave, B.; Maury, J.; Horellou, M.H.; Samama, M. 1980: L-asparaginase, antithrombin III, and thrombosis. Lancet 1(8177): 1091
Astaldi, G.; Burgio, G.R.; Krc, I.; Astaldi, A.; Krcova, V.; Genova, R. 1970: L-asparaginase--an inhibitor of human lymphocyte transformation. Medizinische Klinik 65(10): 451-454
Iqbal, J.; Yaqub, M.; Iqbal, M. 1980: L-asparaginase--antileukemia agent--A review. Jpma. Journal of the Pakistan Medical Association 30(1): 14-17
Biggs, J.C.; Chesterman, C.N.; Holliday, J. 1971: L-asparaginase--clinical experience in leukaemia, lymphoma and carcinoma. Australian and New Zealand Journal of Medicine 1(1): 1-7
Marquardt, H. 1968: L-asparaginase--first specific cytostatic. Arzneimittel-Forschung 18(11): 1380-1386
Perez-Bercoff, R.; Carrara, G.; Cioé, L.; Rita, G.; Caputo, A.; Castelli, L. 1973: L-asparaginase-induced alterations of Burkitt's lymphoma cells. Journal of the National Cancer Institute 50(4): 833-840
Hensley, M.F. 1983: L-asparaginase-induced coagulation abnormalities: report of a case. Journal of the American Osteopathic Association 82(9): 680-681
Chakrabarty, A.K.; Friedman, H. 1970: L-asparaginase-induced immunosuppression: effects on antibody-forming cells and serum titers. Science 167(3919): 869-870
Friedman, H.; Chakrabarty, A.K. 1971: L-asparaginase-induced inhibition of transplantation immunity: prolongation of skin allografts in enzyme-treated mice. Transplantation Proceedings 3(1): 826-830
Ikkala, E. 1969: L-asparaginase. a new antileukemic drug. Duodecim; Laaketieteellinen Aikakauskirja 85(24): 1487-1489
Oettgen, H.F. 1969: L-asparaginase: a new principle in the chemotherapy of malignant neoplasms. Blut 19(6): 351-356
Wriston, J.C.; Yellin, T.O. 1973: L-asparaginase: a review. Advances in Enzymology and Related Areas of Molecular Biology 39: 185-248
Alving, B.M.; Barr, C.F.; Tang, D.B. 1984: L-asparaginase: acute effects on protein synthesis in rabbits with normal and increased fibrinogen production. Blood 63(4): 823-827
Capizzi, R.L.; Bertino, J.R.; Skeel, R.T.; Creasey, W.A.; Zanes, R.; Olayon, C.; Peterson, R.G.; Handschumacher, R.E. 1971: L-asparaginase: clinical, biochemical, pharmacological, and immunological studies. Annals of Internal Medicine 74(6): 893-901
Broome, J.D. 1970: L-asparaginase: early findings and current studies on the metabolism of L-asparagine in lymphoma cells. Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 33: 15-21
Becker, F.F.; Broome, J.D. 1969: L-asparaginase: inhibition of endogenous RNA polymerase activity in regenerating liver. Archives of Biochemistry and Biophysics 130(1): 332-336
Ohno, R.; Harris, J.E.; Hersh, E.M. 1970: L-asparaginase: suppression of the immune response of mice to sheep red blood cells. Clinical and Experimental Immunology 7(2): 221-227
Broome, J.D. 1968: L-asparaginase: the evolution of a new tumor inhibitory agent. Transactions of the new York Academy of Sciences 30(5): 690-704
Haskell, C.M.; Canellos, G.P.; Leventhal, B.G.; Carbone, P.P.; Block, J.B.; Serpick, A.A.; Selawry, O.S. 1969: L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. New England Journal of Medicine 281(19): 1028-1034
Livingston, B.M.; Krakoff, I.H. 1970: L-asparaginase; a new type of anticancer drug. American Journal of Nursing 70(9): 1910-1915
Laboureur, P.; Langlois, C.; Labrousse, M.; Boudon, M.; Emeraud, J.; Samain, J.F.; Ageron, M.; Dumesnil, Y. 1971: L-asparaginases from Escherichia coli. I. Properties of the native forms. Biochimie 53(11): 1147-1156
Laboureur, P.; Langlois, C.; Labrousse, M.; Boudon, M.; Emeraud, J.; Samain, J.F.; Ageron, M.; Dumesnil, Y. 1971: L-asparaginases from Escherichia coli. II. Plurality and origin of molecular forms. Relations with the biological activity. Biochimie 53(11): 1157-1165
Eriksson, C.E. 1967: L-asparagine amidohhdrolase (E. C. 3.5.1.1.) in a commercial preparation of Escherichia coli ATCC 11246. Some properties of the enzyme and its possible use in the determination of l-asparagine. Acta Chemica Scandinavica 21(9): 2573-2575
Ho, D.H.; Whitecar, J.P.; Luce, J.K.; Frei, E. 1970: L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow. Cancer Research 30(2): 466-472
Giner-Sorolla, A.; Kreis, W.; Gryte, C.; Cox, M.L.; Burchenal, J.H. 1972: L-asparaginol and derivatives. Synthesis and screening data. Journal of Medicinal Chemistry 15(9): 978-980
Moe, P.J. 1971: L-asparginase in childhood leukemia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 701-703
Nakano, Y.; Kitaoka, S. 1971: L-aspartate -decarboxylase in a cell-free system from Escherichia coli. Journal of Biochemistry 70(2): 327-334
Wedler, F.C.; Ley, B.W.; Lee, B.H.; O'Leary, M.H.; Kantrowitz, E.R. 1995: L-aspartate association contributes to rate limitation and induction of the T-->R transition in Escherichia coli aspartate transcarbamoylase. Equilibrium exchanges and kinetic isotope effects with a Vmax-enhanced mutant, Asp-236-->Ala. Journal of Biological Chemistry 270(17): 9725-9733
Cobb, A.D.; Knaff, D.B. 1983: L-aspartate transport in the photosynthetic bacterium Chromatium vinosum. Archives of Biochemistry and Biophysics 225(1): 86-94
Tate, S.S.; Meister, A. 1971: L-aspartate-beta-decarboxylase: structure, catalytic activities, and allosteric regulation. Advances in Enzymology and Related Areas of Molecular Biology 35: 503-543
MacDonald, J.F.; Schneiderman, J.H. 1984: L-aspartic acid potentiates 'slow' inward current in cultured spinal cord neurons. Brain Research 296(2): 350-355
Longton, R.W.; Cole, J.S. 1973: L-aspartic and gamma-aminobutyric acids as biochemical agents in producing epithelial lesions. U. S. Navy Medicine 62(2): 12-15
Grümer, H.D.; Hetland, L.B.; Costantini, M.L. 1971: L-benzylalanine as a model amino acid for the study of accumulation diseases. Clinical Chemistry 17(2): 115-118
Grisolía, S.; O'Connor, J.E.; Costell, M. 1984: L-carnitine and ammonia toxicity. Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 139(5): 289-297
Labonia, W.D. 1995: L-carnitine effects on anemia in hemodialyzed patients treated with erythropoietin. American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 26(5): 757-764
Seccombe, D.W.; Snyder, F.; Parsons, H.G. 1982: L-carnitine for methylmalonicaciduria. Lancet 2(8312): 1401
Casciani, C.U.; Caruso, U.; Cravotto, E.; D'Iddio, S.; Corsi, M.; Pola, P.; Savi, L.; Grilli, M. 1982: L-carnitine in haemodialysed patients. Changes in lipid pattern. Arzneimittel-Forschung 32(3): 293-297
Schlenzig, J.S.; Charpentier, C.; Rabier, D.; Kamoun, P.; Sewell, A.C.; Harpey, J.P. 1995: L-carnitine: a way to decrease cellular toxicity of ifosfamide?. European Journal of Pediatrics 154(8): 686-687
Kim, C.S.; Dorgan, D.R.; Roe, C.R. 1984: L-carnitine: therapeutic strategy for metabolic encephalopathy. Brain Research 310(1): 149-153
Stavrovskaia, A.A. 1973: L-cell substrain resistant to metaphase inhibitors. Biulleten' Eksperimental'noi Biologii i Meditsiny 76(9): 112-115
Faras, A.J.; Erikson, R.L. 1969: L-cell virion ribonucleic acid. Journal of Virology 4(1): 31-35
Mul, N.A.; Ballieux, R.E.; Imhof, J.W.; Poen, H.; Kleinveld-Fohrer, A. 1965: L-chain classification of paraproteins. Nederlands Tijdschrift Voor Geneeskunde 109(38): 1796-1797
Asakawa, H.; Toyama, T.; Ando, S.; Okuda, M.; Matsuhashi, C. 1966: L-chain pattern of autoantibodies and antinuclear antibodies of erythrocytes. Saishin Igaku. Modern Medicine 21(2): 403-406
Brorson, J.E.; Lundholm, M.; Seeberg, S. 1973: L-colony production by different strains of Staphylococcus aureus in the absence of antibiotics. Journal of Infectious Diseases 128(3): 335-339
Sundaram, K.S.; Lev, M. 1984: L-cycloserine inhibition of sphingolipid synthesis in the anaerobic bacterium Bacteroides levii. Biochemical and Biophysical Research Communications 119(2): 814-819
Chung, S.H.; Johnson, M.S.; Gronenborn, A.M. 1984: L-cycloserine: a potent anticonvulsant. Epilepsia 25(3): 353-362
Promyslov, M.S.; Sokovnina, I.M. 1973: L-cystathionine content in the brain tissue in certain nervous system diseases. Voprosy Meditsinskoi Khimii 19(1): 66-68
Gebhart, E. 1971: L-cysteine as a protector against the aberration-causing effect of 8-hydroxyquinoline sulfate in human leukocyte chromosomes. Mutation Research 11(2): 261-262
Yu, E.K.; DeVoe, I.W. 1981: L-cysteine oxidase activity in the membrane of Neisseria meningitidis. Journal of Bacteriology 145(1): 280-287
Garweg, G.; Kinsky, I.; Brinkmann, H. 1971: L-cysteine-S35 labelling of the mouse adrenal juxtamedullary X-zone. Zeitschrift für Anatomie und Entwicklungsgeschichte 134(2): 186-199
Federici, G.; Tomati, U.; Santoro, L.; Cannella, C. 1973: L-cysteinsulfinic decarboxylase and L-cysteic decarboxylase in the liver and kidney of mammals. Bollettino della Societa Italiana di Biologia Sperimentale 49(11): 675-678
Csanda, E.; Tárczy, M.; Takáts, A.; Mogyorós, I.; Köves, A.; Katona, G. 1983: L-deprenyl in the treatment of Parkinson's disease. Journal of Neural Transmission. Supplementum 19: 283-290
Birkmayer, W.; Riederer, P.; Linauer, W.; Knoll, J. 1984: L-deprenyl plus L-phenylalanine in the treatment of depression. Journal of Neural Transmission 59(1): 81-87
Mann, J.; Gershon, S. 1980: L-deprenyl, a selective monoamine oxidase type-B inhibitor in endogenous depression. Life Sciences 26(11): 877-882
Cooper, J.M.; Daniel, S.E.; Marsden, C.D.; Schapira, A.H. 1995: L-dihydroxyphenylalanine and complex i deficiency in Parkinson's disease brain. Movement Disorders: Official Journal of the Movement Disorder Society 10(3): 295-297
Opacka-Juffry, J.; Brooks, D.J. 1995: L-dihydroxyphenylalanine and its decarboxylase: new ideas on their neuroregulatory roles. Movement Disorders: Official Journal of the Movement Disorder Society 10(3): 241-249
Wurtman, R.J.; Rose; Matthysse, S.; Stephenson, J.; Baldessarini, R. 1970: L-dihydroxyphenylalanine: effect on S-adenosylmethionine in brain. Science 169(3943): 395-397
Liu, Y.P.; Ambani, L.M.; Van Woert, M.H. 1972: L-dihydroxyphenylalanine: effect on levels of amino acids in rat brain. Journal of Neurochemistry 19(9): 2237-2239
Liu, Y.P.; Ambani, L.M.; Van Woert, M.H. 1974: L-dihydroxyphenylalanine: effect on levels of free amino acids in rat liver. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 147(1): 154-157
Räihä, N.; Vapaavuori, E. 1970: Artificial ventilation of the very small premature infant with respiratory insufficiency. Biology of the Neonate 16(1): 184-186
Barbeau, A. 1970: L-dopa and Parkinson's disease. L'Union Medicale du Canada 99(12): 2195-2197
Castaldo, V.; Krynicki, V.E.; Crade, M. 1973: L-dopa and REM sleep in normal and mentally retarded subjects. Biological Psychiatry 6(3): 295-299
Matthysse, S.; Lipinski, J.; Shih, V. 1971: L-dopa and S-adenosylmethionine. Clinica Chimica Acta; International Journal of Clinical Chemistry 35(1): 253-254
Vorlaender, K.O. 1970: Allergic diseases of the cardiovascular system. Deutsches Medizinisches Journal 21(19): 1209-1215
Parkes, J.D.; Zilkha, K.J.; Knill-Jones, R.P.; Clements, P.J.; Baxter, R. 1971: L-dopa and amantadine hydrochloride in Parkinson's disease. Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(3): 356-360
Parkes, J.D.; Knill-Jones, R.P.; Clements, P.J. 1971: L-dopa and amantadine hydrochloride in extra-pyramidal disorders. Postgraduate Medical Journal 47(544): 116-119
Weeth, J.B.; Shealy, C.N.; Mercier, D.A. 1969: L-dopa and amantadine in the therapy of parkinsonism. Wisconsin Medical Journal 68(11): 325-328
Umbach, W. 1966: L-dopa and amphetamine treatment of acinetic Parkinsonism patients with and without stereotaxic surgery. Beitrage Zur Neurochirurgie 13: 45-51
Maltau, J. 1971: L-dopa and anesthesia. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(19): 1481
Horvath, T.B.; Meares, R.A. 1974: L-dopa and arousal. Journal of Neurology Neurosurgery and Psychiatry 37(4): 416-420
Popovic, V.P.; Horecky, J.; Popovic, P. 1970: A miniaturized pump oxygenator for evaluation of peripheral circulatory changes induced by long-term weightlessness in rats. Space Life Sciences 2(1): 113-115
Ingvarsson, G. 1965: L-dopa and bronchial asthma. Preliminary report. Nordisk Medicin 74(46): 1166-1167
Landsberg, L. 1972: L-dopa and cardiac arrhythmia. New England Journal of Medicine 286(4): 218
Mars, H.; Krall, J. 1971: L-dopa and cardiac arrhythmias. New England Journal of Medicine 285(25): 1437
Weiner, W.; Harrison, W.; Klawans, H. 1969: L-dopa and cerebrospinal fluid homovanillic acid in Parkinsonism. Life Sciences 8(17): 971-976
Angel, R.W.; Alston, W.; Garland, H. 1971: L-dopa and error correction time in Parkinson's disease. Neurology 21(12): 1255-1260
Braham, J.; Sarova-Pinhas, I. 1971: L-dopa and favism. Blood 37(6): 744-745
MacIntyre, I.M.; Strange, D.M.; Beavis, J.P. 1971: L-dopa and general anaesthesia. Anaesthesia 26(3): 370-372
Evered, D.F. 1971: L-dopa and its combination with pyridoxal 5'-phosphate. Lancet 2(7714): 46
Barbeau, A. 1969: L-dopa and juvenile Huntington's disease. Lancet 2(7629): 1066
Hällström, T.; Persson, T. 1970: L-dopa and non-emission of semen. Lancet 1(7658): 1231-1232
Sacks, O.W.; Kohl, M. 1970: L-dopa and oculogyric crises. Lancet 2(7665): 215-216
Okihiro, M.M. 1971: L-dopa and parkinsonism. Hawaii Medical Journal 30(5): 390-392
Pakkenberg, H. 1969: L-dopa and parkinsonism. A preliminary report. Ugeskrift for Laeger 131(22): 959-960
Johnston, G.A. 1971: L-dopa and pyridoxal 5'-phosphate: tetrahydroisoquinoline formation. Lancet 1(7708): 1068
Giordano, G.; Marugo, M.; Minuto, F.; Barreca, T.; Foppiani, E. 1973: L-dopa and somatotropin secretion in humans. Folia Endocrinologica 26(6): 523-537
Steiner, J.A.; Low, P.A.; Huang, C.Y.; West, M.; Uther, J.B.; Allsop, J.L.; Chalmers, J.P. 1974: L-dopa and the Shy-Drager syndrome. Medical Journal of Australia 2(4): 133-136
Ducloux, G.; Mouton, Y.; Warembourg, H. 1972: L-dopa and the cardiologist. Annales de Cardiologie et d'Angeiologie 21(6): 545-553
Klawans, H.L.; Erlich, M. 1969: L-dopa and the negative symptoms of Parkinsonism. Journal of Neurology Neurosurgery and Psychiatry 32(5): 460-461
Fangman, A.; O'Malley, W.E. 1969: L-dopa and the patient with Parkinson's disease. American Journal of Nursing 69(7): 1455-1457
Streifler, M.; Avrami, E.; Rabey, J.M. 1980: L-dopa and the secretion of sebum in Parkinsonian patients. European Neurology 19(1): 43-48
Knobel, M.; Karniol, I.G.; Strauss, L. 1981: L-dopa and treatment of hyperactive children. Acta Paedopsychiatrica 47(1): 27-31
Kabes, J.; Taussigová, D.; Dostál, T.; Vinar, O. 1974: L-dopa and tricyclic antidepressants in affective disorders. a pilot study. Activitas Nervosa Superior 16(3): 186-188
Johnston, G.A. 1971: L-dopa and vitamin B 6. Lancet 2(7717): 220-221
Vladyka, V. 1973: L-dopa as a substitution for surgery in Parkinsonism?. Ceskoslovenska Neurologie a Neurochirurgie 36(6): 337-341
Honda, K. 1971: L-dopa as a therapeutic agent. Japanese Journal for Public Health Nurse 27(11): 66-67
Evered, D.F. 1971: L-dopa as a vitamin-B6 antagonist. Lancet 1(7705): 914
Ward, C.D.; Trombley, I.K.; Calne, D.B.; Kopin, I.J. 1984: L-dopa decarboxylation in chronically treated patients. Neurology 34(2): 198-201
Fahn, S. 1972: L-dopa effect in Huntington's chorea. New England Journal of Medicine 287(9): 467-468
Römer, F.; Bettag, W.; Bock, W.J. 1971: L-dopa effect in Parkinson's syndrome. Zeitschrift für Allgemeinmedizin 47(6): 281-283
Horne, D.J. 1974: L-dopa effects on motor and "central programming" deficits in Parkinsonism. Psychopharmacologia 36(2): 175-180
Gillen, H.W. 1973: L-dopa for Parkinson's disease; some limitations in its use. Medical Trial Technique Quarterly 19(4): 400-408
Anonymous 1969: L-dopa for Parkinsonism. Drug and Therapeutics Bulletin 7(15): 59-60
Reveno, W.S.; Bauer, R.B.; Rosenbaum, H. 1973: L-dopa for parkinsonism. Geriatrics 28(1): 86-88
Krasner, N.; Cornelius, J.M. 1970: L-dopa for postencephalitic Parkinsonism. British Medical Journal 4(5733): 496
Sacks, O.W. 1969: L-dopa for progressive suparanulcear palsy. Lancet 2(7620): 591-592
Wagshul, A.; Daroff, R.B. 1969: L-dopa for progressive supranuclear palsy. Lancet 2(7611): 105-106
Parish, L.C. 1970: L-dopa for seborrheic dermatitis. New England Journal of Medicine 283(16): 879
Antonaccio, M.J.; Robson, R.D. 1974: L-dopa hypotension in dogs: evidence for mediation through 5-HT release. Archives Internationales de Pharmacodynamie et de Therapie 212(1): 89-102
Vignalou, J.; Beck, H. 1973: L-dopa in 122 cases of Parkinson's disease in patients over 70 years old. Comparative study with a group of Parkinsonian patients who are 41 to 69 years old. Gerontologia Clinica 15(1): 50-64
Lewis, I. 1971: L-dopa in Parkinson's disease. A report on 95 cases and review of the literature. Journal of the Medical Association of the State of Alabama 40(11): 709-718
Filho, R.M.; de Karam, G.M. 1971: L-dopa in Parkinson's syndrome. Revista Brasileira de Medicina 28(5): 220-231
Hughes, R.C.; Polgar, J.G.; Weightman, D.; Walton, J.N. 1971: L-dopa in Parkinsonism and the influence of previous thalamotomy. British Medical Journal 1(5739): 7-13
Klawans, H.L.; Zeitlin, E. 1971: L-dopa in Parkinsonism associated with cerebellar dysfunction (probable olivopontocerebellar degeneration). Journal of Neurology Neurosurgery and Psychiatry 34(1): 14-19
Ng, L.K.; Chase, T.N.; Colburn, R.W.; Kopin, I.J. 1972: L-dopa in Parkinsonism. a possible mechanism of action. Neurology 22(7): 688-696
Anonymous 1970: L-dopa in chronic manganese poisoning. Lancet 1(7640): 229
Bunney, W.E.; Murphy, D.L.; Brodie, H.K.; Goodwin, F.K. 1970: L-dopa in depressed patients. Lancet 1(7642): 352
Calne, D.B.; Stern, G.M.; Spiers, A.S.; Laurence, D.R. 1969: L-dopa in idiopathic parkinsonism. Lancet 2(7628): 973-976
Yahr, M.D. 1972: L-dopa in neurological disease: current status. Research Publications - Association for Research in Nervous and Mental Disease 50: 494-511
Cotzias, G.C.; Papavasiliou, P.S.; Gellene, R. 1969: L-dopa in parkinson's syndrome. New England Journal of Medicine 281(5): 272
Nahum, L.H. 1970: L-dopa in parkinsonism. Connecticut Medicine 34(6): 396-398
Calne, D.B.; Stern, G.M.; Laurence, D.R.; Sharkey, J.; Armitage, P. 1969: L-dopa in postencephalitic parkinsonism. Lancet 1(7598): 744-746
Dehaene, I.; Bogaerts, M. 1970: L-dopa in progressive supranuclear palsy. Lancet 2(7670): 470
Van Woert, M.H.; Heninger, G.; Rathey, U.; Bowers, M.B. 1970: L-dopa in senile dementia. Lancet 1(7646): 573-574
Serrano, P.A.; Lona, R.; Domínguez de la Piedra, O.; Carrasco-Zanini, J.; Carrillo, A.A.; Zaldivar, H.M. 1972: L-dopa in sexual impotence in the diabetic. La Prensa Medica Mexicana 37(5): 163-166
Ulrich, G. 1974: L-dopa in the apallic syndrome. Medizinische Monatsschrift 28(3): 93-94
Piccinin, G.L.; Piccirilli, M.; Morocutti, C. 1982: L-dopa in the therapy of Parkinson's disease today. La Clinica Terapeutica 100(2): 189-202
Martin, W.E. 1970: L-dopa in the treatment of Parkinson's disease. Postgraduate Medicine 47(6): 153-157
Poch, G.F. 1969: L-dopa in the treatment of Parkinson's disease. Preliminary report. Prensa Medica Argentina 56(34): 1629-1632
Brezný, I.; Buranová, D.; Cernácek, J.; Trávniková, M. 1972: L-dopa in the treatment of Parkinsonism. Activitas Nervosa Superior 14(2): 96
Harries, J.R. 1972: L-dopa in the treatment of Parkinsonism in Africans. East African Medical Journal 49(2): 112-115
Stellar, S.; Mandell, S.; Waltz, J.M.; Cooper, I.S. 1970: L-dopa in the treatment of Parkinsonism; a preliminary appraisal. Journal of Neurosurgery 32(3): 275-280
Haleem, M.A. 1972: L-dopa in the treatment of parkinsonism. Gerontologia Clinica 14(4): 242-248
Wycis, H.T.; Cunningham, W.; Kellett, G.; Spiegel, E.A. 1970: L-dopa in the treatment of post-surgical Parkinson patients. Journal of Neurosurgery 32(3): 281-285
Apostol-Pruskauer, B.; Voiculescu, V. 1973: L-dopa in the treatment of the Parkinsonian syndrome. Neurologia Psihiatria Neurochirurgia 18(6): 539-549
Butcher, L.; Engel, J.; Fuxe, K. 1970: L-dopa induced changes in central monoamine neurons after peripheral decarboxylase inhibition. Journal of Pharmacy and Pharmacology 22(4): 313-316
Mones, R.J.; Elizan, T.S.; Siegel, G. 1970: L-dopa induced dyskinesias in 152 patients with Parkinson's disease. Transactions of the American Neurological Association 95: 286-287
Lucke, C.; Höffken, B.; Morgner, K.D. 1974: L-dopa induced growth hormone secretion. Comparison with insulin tolerance test, arginine infusion and sleep induced GH-secretion. Acta Endocrinologica 77(2): 241-249
George, D.T.; Rayfield, E.J. 1974: L-dopa induced plasma glucagon release. Journal of Clinical Endocrinology and Metabolism 39(3): 618-621
Ikeda, H.; Baba, O.; Ishino, H. 1972: L-dopa induced psychosis-dyskinesia complex. No to Shinkei 14(3): 275-280
Birkmayer, W.; Danielcyk, W.; Neumayer, E.; Riederer, P. 1973: L-dopa level in plasma, primary condition for the kinetic effect. Journal of Neural Transmission 34(2): 133-143
Pederzoli, M.; Girotti, F.; Scigliano, G.; Aiello, G.; Carella, F.; Caraceni, T. 1983: L-dopa long-term treatment in Parkinson's disease: age-related side effects. Neurology 33(11): 1518-1522
Sovilla, J.Y.; Schorderet, M. 1982: L-dopa mediated accumulation of cyclic AMP in isolated rabbit retinae in vitro. Effects of light and/or pharmacological factors. Life Sciences 31(19): 2081-2092
Sandler, M. 1972: L-dopa metabolism in man (with special reference to parkinsonism). Scientific Basis of Medicine Annual Reviews 1972: 161-173
Tice, L.F. 1972: L-dopa or methyldopa?. American Journal of Pharmacy and the Sciences Supporting Public Health 144(3): 71-72
Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; Pohlmeier, H. 1970: L-dopa plus decarboxylase inhibitor in depression. Lancet 2(7674): 660-661
Sturner, W.Q.; Garriott, J.C. 1972: L-dopa poisoning. Journal of Forensic Sciences 17(3): 440-443
Ghika, J.; De Tribolet, N.; Regli, F.; Uské, A. 1993: L-dopa resistant parkinsonism in an adult woman with a cyst in the posterior fossa. Schweizer Archiv für Neurologie und Psychiatrie 144(5): 475-480
Sonntag, W.E.; Forman, L.J.; Miki, N.; Trapp, J.M.; Gottschall, P.E.; Meites, J. 1982: L-dopa restores amplitude of growth hormone pulses in old male rats to that observed in young male rats. Neuroendocrinology 34(3): 163-168
Coleman, M.P.; Barnet, A. 1969: L-dopa reversal of muscular spasm, vomiting and insomnia in a patient with an atypical form of familial dystonia. Transactions of the American Neurological Association 94: 91-95
Strohfus, S. 1970: L-dopa therapy and intense individual care help Parkinson patients gain function and control. Modern Nursing Home 25(1): 37-40
Vasin, N.I.; Il'inskiĭ, I.A.; Safronov, V.A. 1974: L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(5): 701-706
Murray, T.J. 1972: L-dopa therapy in Parkinson's disease. Nova Scotia Medical Bulletin 51(3): 67-70
Barbeau, A. 1969: L-dopa therapy in Parkinson's disease: a critical review of nine years' experience. Canadian Medical Association Journal 101(13): 59-68
Dubiel, J.P.; Ciba, T. 1970: Sadamin and Complamin in the treatment of coronary disease. Polski Tygodnik Lekarski 25(52): 2038-2040
Sandler, M. 1971: L-dopa therapy in parkinsonism: mechanism of action. Psychiatria Neurologia Neurochirurgia 74(4): 331-333
Muenter, M.D.; Tyce, G.M. 1971: L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects. Mayo Clinic Proceedings 46(4): 231-239
Kendel, K.; Rüther, E.; Beck, U.; Meier-Ewert, K. 1973: L-dopa therapy of narcolepsy. Observation of clinical course and polygraphic EEG night sleep and day leads. Der Nervenarzt 44(8): 434-436
Mawatari, S.; Izumi, K.; Kuroiwa, Y. 1972: L-dopa treatment and vitamin B 6 --clinical and chemical studies. Rinsho Shinkeigaku 12(2): 105-109
Rivera-Calimlim, L.; Dujovne, C.A.; Morgan, J.P.; Lasagna, L.; Bianchine, J.R. 1970: L-dopa treatment failure: explanation and correction. British Medical Journal 4(5727): 93-94
Rinne, U.K.; Sonninen, V.; Sürtola, T. 1970: L-dopa treatment in Parkinson's disease. Acta Neurologica Scandinavica 46(S43): 221-222
Chen, K.M. 1971: L-dopa treatment of Parkinson's disease. Journal of the Formosan Medical Association 70(7): 424-430
Dalle Ore, G.; Da Pian, R.; Bazzan, A.; Giombini, S.; Solero, C.L.; Maschio, A. 1970: L-dopa treatment of Parkinson's disease. Results after one year. Sistema Nervoso 22(2): 92-98
Bauer, R.B.; Stevens, C.; Reveno, W.S.; Rosenbaum, H. 1982: L-dopa treatment of Parkinson's disease: a ten-year follow up study. Journal of the American Geriatrics Society 30(5): 322-325
Maier, C. 1972: L-dopa treatment of idiopathic orthostatic hypotension (postural hypotension). Schweizerische Medizinische Wochenschrift 102(40): 1412-1414
Szulc-Kuberska, J.; Niewodniczy, A.; Poźniak-Patewicz, E.; Wolczyk-Orzechowska, M. 1973: L-dopa treatment of parkinsonism. Neurologia i Neurochirurgia Polska 7(1): 63-68
Reveno, W.S.; Bauer, R.B.; Rosenbaum, H. 1971: L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride. Geriatrics 26(8): 61-70
Antonini, F.; Baroni, A.; Roveyaz, L. 1970: L-dopa treatment of persons with parkinsonism in a hospital for geriatric rehabilitation. Sistema Nervoso 22(2): 74-81
Greenberg, J. 1969: L-dopa treatment too successful. New England Journal of Medicine 281(11): 621
Angus, S. 1970: L-dopa with MK 485 for depression. Lancet 1(7658): 1231
Wasilewski, R. 1981: L-dopa with inhibitor in the treatment of parkinsonian syndrome-results of long-term observations. Neurologia i Neurochirurgia Polska 15(4): 411-416
Knopp, W.; Rotenberg, M.; Boye, R. 1972: L-dopa, Parkinson's disease and pupillary reaction to light. Monographs in Human Genetics 6: 198
Murphy, D.L. 1972: L-dopa, behavioral activation and psychopathology. Research Publications - Association for Research in Nervous and Mental Disease 50: 472-493
Murphy, D.L.; Goodwin, F.K.; Brodie, H.K.; Bunney, W.E. 1973: L-dopa, dopamine, and hypomania. American Journal of Psychiatry 130(1): 79-82
DiPalma, J.R. 1971: L-dopa, new hope for C.N.S. disease. Rn 34(3): 63-70
Damásio, A.R.; Antunes, J.L.; Macedo, C. 1970: L-dopa, parkinsonism, and depression. Lancet 2(7673): 611-612
Mayer, R.F. 1974: L-dopa, parkinsonism, and involuntary movements. Transactions of the American Neurological Association 99: 163-166
Anonymous 1971: L-dopa--MAO inhibitors. Delaware Medical Journal 43(8): 236
Kuruma, I.; Bartholini, G.; Pletscher, A. 1970: L-dopa-induced accumulation of 3-O-metyldopa in brain and heart. European Journal of Pharmacology 10(2): 189-192
Weintraub, M.I.; Gaasterland, D.; van Woert, M. 1970: L-dopa-induced anisocoria in latent Horner's syndrome. Neurology 20(4): 417
Baker, L.L.; Chandler, S.H.; Goldberg, L.J. 1984: L-dopa-induced locomotor-like activity in ankle flexor and extensor nerves of chronic and acute spinal cats. Experimental Neurology 86(3): 515-526
Steck, A.J.; Hamilton, L.D. 1972: L-dopa-induced modification of DNA, RNA and protein synthesis. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 140(1): 172-175
Dell'Aria, V.; Ciannella, L.; Melone, M.A. 1981: L-dopa-resistant Parkinson's disease with cerebral atrophy: striato-nigral degeneration?. Acta Neurologica. Quaderni 42: 212-215
Jankovic, J. 1981: L-dopa-resistant Parkinsonism due to dopa decarboxylase deficiency?. Annals of Neurology 10(1): 64-65
Dell'Aria, V.; Ciannella, L.; Melone, M.A. 1981: L-dopa-resistant parkinsonism with cerebral atrophy: striato-nigral degeneration? 2 cases. Acta Neurologica 3(1): 212-215
Lander, H.L. 1971: L-dopa-variation in response with different pharmaceutical preparations (Syndopa vs. Larodopa). Medical Journal of Australia 2(19): 984
Green, J.R. 1970: L-dopa. A remarkable contribution to medical practice. Arizona Medicine 27(7): 17
Alexander, P. 1970: Prospects for immunotherapy of cancer: experience in experimental systems. British Medical Journal 4(5733): 484-486
Trost, G. 1970: Construction of phantom models with rubber impressions for visual education. Dental Abstracts; a Selection of World Dental Literature 15(10): 352-358
Herskovits, E.; Matera, R.; Figueroa Gacitua, E. 1971: L-dopa: causes of its failure and intolerance and its treatment. Prensa Medica Argentina 58(37): 1825-1828
Weiss, B.F.; Munro, H.N.; Wurtman, R.J. 1971: L-dopa: disaggregation of brain polysomes and elevation of brain tryptophan. Science 173(3999): 833-835
Guthrie, T.C.; Dunbar, H.S.; Weider, A. 1970: L-dopa: effect on highest integrative functions in Parkinsonism. Transactions of the American Neurological Association 95: 250-252
Carrasco, H.A.; Lozano, J.; Lang, T.W.; Meerbaum, S. 1971: L-dopa: its effect on the cardiovascular system. Geriatrics 26(9): 100-108
Schönfeld, J.K. 1967: L-form bacteria. Nederlands Tijdschrift Voor Geneeskunde 111(25): 1133-1135
Kochemasova, Z.N.; Dykhno, M.M.; Prozorovskiĭ, S.V.; Kassirskaia, N.G.; Burmistrovich, S.F.; Savenkova, V.T.; Shchegolev, A.G.; Starshinova, V.S. 1965: L-form of some types of pathogenic bacteria. Vestnik Akademii Meditsinskikh Nauk SSSR 20(8): 39-46
Rhodes, D.; Brosman, S.; Kalmanson, G.; Guze, L. 1973: L-forms and urinary tract infections. Urology 1(2): 114-116
Madoff, S. 1970: L-forms from Streptococcus MG: induction and characterization. Annals of the new York Academy of Sciences 174(2): 912-921
Shmelev, N.A.; Dorozhkova, I.R.; Zemskova, Z.S. 1974: L-forms of BCG Mycobacteria and their capacity to induce morphological reactions inherent in the BCG vaccine. Problemy Tuberkuleza 1: 62-70
Wang, Q.X. 1984: L-forms of Brucella. Zhonghua Liu Xing Bing Xue Za Zhi 5(5): 314-317
Prozorovskiĭ, S.V.; Levina, G.A.; Kotliarova, G.A. 1968: L-forms of Dipl. pneumoniae obtained under the action of penicillin. Antibiotiki 13(10): 902-907
Gerkowicz, T. 1968: L-forms of E. coli and Proteus in experimental pyelonephritis in rats. Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 23: 197-204
Welshimer, H.J.; Meredith, A.L. 1972: L-forms of Listeria monocytogenes. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. Erste Abteilung Originale. Reihe A: Medizinische Mikrobiologie und Parasitologie 219(1): 105-108
Kalvodová, D. 1974: L-forms of Listeria monocytogenes. Induction in vitro and sensitivity to antibiotics. Ceskoslovenska Epidemiologie Mikrobiologie Imunologie 23(4-5): 276-281
Sukhodolskaya, A.E. 1972: L-forms of Mycobacterium tuberculosis (review of the literature). Vrachebnoe Delo 3: 83-86
Karachunskiĭ, M.A.; Dorozhkova, I.R.; Kaminskaia, A.A.; Abdullaeva, E.T. 1983: L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis. Problemy Tuberkuleza 7: 38-43
Hubert, E.G.; Potter, C.S.; Hensley, T.J.; Cohen, M.; Kalmanson, G.M.; Guze, L.B. 1971: L-forms of Pseudomonas aeruginosa. Infection and Immunity 4(1): 60-72
Havlícková, H.; Havlícek, J. 1972: L-forms of Streptococcus pyogenes: their growth in liquid media. Ceskoslovenska Epidemiologie Mikrobiologie Imunologie 21(4): 182-190
Ustimenko, L.M. 1965: L-forms of Treponema pallidum. Vestnik Akademii Meditsinskikh Nauk SSSR 20(8): 46-50
Ovchinnikov, N.M.; Delektorskiĭ, V.V.; Ustimenko, L.M. 1970: L-forms of Treponema pallidum (electron microscopic studies). Vestnik Dermatologii i Venerologii 44(8): 53-57
Patocka, F.; Kalvodová, D. 1969: L-forms of corynebacterium pyogenes hominis. Ceskoslovenska Epidemiologie Mikrobiologie Imunologie 18(5): 284-289
Kagan, G.I.; Koptelova, E.I.; Chumachenko, N.V.; Rakovskaia, I.V.; Vul'fovich, I.V. 1972: L-forms of hemolytic streptococcus in experimental infection of Macaca rhesus monkeys. Biulleten' Eksperimental'noi Biologii i Meditsiny 73(7): 79-81
Crane, J.; Smith, F. 1995: L-forms of staphylococci and streptococci. Veterinary Record 136(15): 400
Panos, C. 1967: L-forms, lipid alterations and inhibition of cell wall biosynthesis. Annals of the new York Academy of Sciences 143(1): 152-157
Anonymous 1972: L-forms--pathogenic or not?. Lancet 1(7742): 130-131
Sakagishi, Y.; Kaneko, I. 1972: L-fucose. Rinsho Byori. Japanese Journal of Clinical Pathology 20: Suppl. 2: 119-31
Bridges, R.J.; Griffith, O.W.; Meister, A. 1980: L-gamma-(Threo-beta-methyl)glutamyl-L-alpha-aminobutyrate, a selective substrate of alpha-glutamyl cyclotransferase. Journal of Biological Chemistry 255(22): 10787-10792
Gmelin, R.; Larsen, P.O. 1967: L-gamma-ethylideneglutamic acid and L-gamma-methyleneglutamic acid in seeds of Tetrapleura tetraptera (Schum. et Thonn.) Taub. (Mimosaceae). Biochimica et Biophysica Acta 136(3): 572-573
Austin, S.J.; Schwimmer, S. 1971: L-gamma-glutamyl peptidase activity in sprouted onion. Enzymologia 40(5): 273-285
Hultberg, B.; Sjögren, U. 1980: L-gamma-glutamyl transpeptidase activity in normal and leukemic leukocytes. Acta Haematologica 63(3): 132-135
Sánchez-Medina, F.; Mayor, F. 1970: L-glutamate 1-carboxylase and 4-aminobutyrate: 2-oxoglutarate aminotransferase in succulent plants. Revista Espanola de Fisiologia 26(3): 217-224
Foster, A.C.; Fagg, G.E.; Mena, E.E.; Cotman, C.W. 1981: L-glutamate and L-aspartate bind to separate sites in rat brain synaptic membranes. Brain Research 229(1): 246-250
De Barry, J.; Langley, O.K.; Vincendon, G.; Gombos, G. 1982: L-glutamate and L-glutamine uptake in adult rat cerebellum: an autoradiographic study. Neuroscience 7(5): 1289-1297
Kelly, J.S.; Gage, P.W. 1969: L-glutamate blockade of transmission at the giant synapse of the squid stellate ganglion. Journal of Neurobiology 1(2): 209-219
Kataoka, K.; Bak, I.J.; Hassler, R.; Kim, J.S.; Wagner, A. 1974: L-glutamate decarboxylase and choline acetyltransferase activity in the substantia nigra and the striatum after surgical interruption of the strio-nigral fibres of the baboon. Experimental Brain Research 19(2): 217-227
Cozzani, I. 1973: L-glutamate decarboxylase. a survey on the regulation and possible function in different organism. Acta Vitaminologica et Enzymologica 27(1): 191-196
Francesconi, R.P.; Villee, C.A. 1968: L-glutamate dehydrogenase in rat and human fetal liver slices. Biochemical and Biophysical Research Communications 31(5): 713-722
Pearce, B.R.; Dutton, G.R. 1982: L-glutamate increases the spontaneous release of [3H]GABA from cultured cerebellar neurons. Brain Research 255(3): 492-496
Fagg, G.E.; Matus, A. 1984: L-glutamate receptor heterogeneity: labeling of distinct receptor sub-types using radioligand binding techniques. Journal of Receptor Research 4(1-6): 201-217
Fagg, G.E.; Mena, E.E.; Cotman, C.W. 1983: L-glutamate receptor populations in synaptic membranes: effects of ions and pharmacological characteristics. Advances in Biochemical Psychopharmacology 37: 199-209
Chang, H.H.; Michaelis, E.K. 1981: L-glutamate stimulation of Na+ efflux from brain synaptic membrane vesicles. Journal of Biological Chemistry 256(19): 10084-10087
Sacktor, B. 1981: L-glutamate transport in renal plasma membrane vesicles. Molecular and Cellular Biochemistry 39: 239-251
Shieh, K.Z.; Hedrick, L.R. 1969: L-glutamate uptake and metabolism by Hansenula subpelliculosa. Antonie van Leeuwenhoek 35: Suppl:g1-2
Winter, C.R.; Baker, R.C. 1995: L-glutamate-induced changes in intracellular calcium oscillation frequency through non-classical glutamate receptor binding in cultured rat myocardial cells. Life Sciences 57(21): 1925-1934
Drummond, R.J.; Phillips, A.T. 1974: L-glutamic acid decarboxylase in non-neural tissues of the mouse. Journal of Neurochemistry 23(6): 1207-1213
Haber, B.; Kuriyama, K.; Roberts, E. 1970: L-glutamic acid decarboxylase: a new type in glial cells and human brain gliomas. Science 168(3931): 598-599
Schoffeniels, E. 1966: L-glutamic acid dehydrogenase activity and osmoregulation. Archives Internationales de Physiologie et de Biochimie 74(2): 333-335
Steiner, F.A. 1969: L-glutamic acid, gamma-aminobutyric acid and pyridoxal-5'-phosphate at the level of the single unit in rat brain. Annals of the new York Academy of Sciences 166(1): 199-209
Brandon, C.; Lam, D.M. 1983: L-glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas. Proceedings of the National Academy of Sciences of the United States of America 80(16): 5117-5121
Desser, H.; Höcker, P. 1974: L-glutaminase activity in lymphocytes of patients with chronic lymphatic leukemia. Clinica Chimica Acta; International Journal of Clinical Chemistry 53(2): 191-196
Giordano, C.; Esposito, R.; Mazzola, G.; Vecchio, G.; Pluvio, M.; Cirillo, D.; Capasso, G.B.; Buonanno, G. 1981: L-glutaminase and L-asparaginase by extracorporeal route in acute lymphoblastic leukemia therapy. International Journal of Artificial Organs 4(5): 244-248
Hersh, E.M. 1971: L-glutaminase: suppression of lymphocyte blastogenic responses in vitro. Science 172(3984): 736-738
Tourian, A.; Callahan, M.; Hung, W. 1983: L-glutamine D-fructose-6-P aminotransferase regulation by glucose-6-P and UDP-N-acetylglucosamine. Neurochemical Research 8(12): 1589-1595
Calcagno, M.; Levy, J.A.; Arrambide, E.; Mizraji, E. 1971: L-glutamine D-fructose-6-phosphate amidotransferase of chick cartilage. Evidence for a random mechanism. Enzymologia 41(3): 174-182
LéJohn, H.B. 1983: L-glutamine alteration of gene expression, not of polyphosphate and calcium metabolism, is a key event in arresting fungal sporulation. Canadian Journal of Biochemistry and Cell Biology 61(5): 262-273
Novak, E.K.; Phillips, A.W. 1974: L-glutamine as a substrate for L-asparaginase from Serratia marcescens. Journal of Bacteriology 117(2): 593-600
Moosa, A.; Hughes, E.A. 1974: L-glutamine therapy in Leigh's encephalomyelopathy. Archives of Disease in Childhood 49(3): 246
Zwierz, K.; Bialobrzeska, J.; Popowicz, J. 1969: L-glutamine: D-fructose-6-phosphate aminotransferase (EC 2.6.1.16) activity in mammalian tissues. Acta Biologica Academiae Scientiarum Hungaricae 20(1): 75-83
Rubino, A.; La Torretta, G.; Di Martino, D.; Pierro, M.; Vetrella, M.; Auricchio, S. 1967: L-glutaminyl-L-proline dipeptidase and glycyl-L-proline dipeptidase in the small intestine of the human fetus. La Pediatria 75(5): 770-779
Fosker, A.P.; Law, H.D. 1965: L-glutamyl-gamma-aminobutyric acid and related compounds. Journal of the Chemical Society. Perkin Transactions 1 1965: 7305-7312
Lee, Y.P.; Craine, J.E. 1971: L-glycerol 3-phosphate dehydrogenase. I. Effects of the substrates on the catalytic properties of the hepatic nicotinamide adenine dinucleotide-linked enzyme from the rabbit. Journal of Biological Chemistry 246(24): 7616-7622
Okamura, H.; Nishida, T.; Nakagawa, H. 1974: L-histidine ammonia-lyase in rat liver. I. Purification and general characteristics. Journal of Biochemistry 75(1): 139-152
Yatsunami, K. 1995: L-histidine decarboxylase gene: its structure and transcriptional regulation. Seikagaku. Journal of Japanese Biochemical Society 67(3): 229-233
Polkinghorne, M.A.; Hynes, M.J. 1982: L-histidine utilization in Aspergillus nidulans. Journal of Bacteriology 149(3): 931-940
Bryce, G.F.; Roeske, R.W.; Gurd, R.N. 1966: L-histidine-containing peptides as models for the interaction of copper (II) and nickel (II) ions with sperm whale apomyoglobin. Journal of Biological Chemistry 241(5): 1072-1080
Warrington, R.C.; Fang, W.D. 1982: L-histidinol protection against cytotoxic action of cytosine arabinoside and 5-fluorouracil in cultured mouse spleen cells. Journal of the National Cancer Institute 68(2): 279-286
Rufo, M.B.; Fishman, W.H. 1972: L-homoarginine, a specific inhibitor of liver-type alkaline phosphatase, applied to the recognition of liver-type enzyme activity in rat intestine. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 20(5): 336-343
Fishman, W.; Sie, H.G. 1970: L-homoarginine; an inhibitor of serum "bone and liver" alkaline phosphatase. Clinica Chimica Acta; International Journal of Clinical Chemistry 29(2): 339-341
Tanemura, K.; Sasaki, T.; Okazaki, M. 1971: L-hydroxyamino acid(L-serine, L-threonine)-sulfate sulfatase activity in the serum and human tissue. Rinsho Byori. Japanese Journal of Clinical Pathology 19(Suppl): 364
Matalon, R.; Cifonelli, J.A.; Dorfman, A. 1971: L-iduronidase in cultured human fibroblasts and liver. Biochemical and Biophysical Research Communications 42(2): 340-345
Churchich, J.E. 1972: L-kynurenine: a fluorescent probe of serum albumins. Biochimica et Biophysica Acta 285(1): 91-98
Gál, E.M.; Sherman, A.D. 1980: L-kynurenine: its synthesis and possible regulatory function in brain. Neurochemical Research 5(3): 223-239
Ricci, G.; Federici, G.; Lucente, G.; Achilli, M.; Cavallini, D. 1982: L-lanthionine oxidation by snake venom L-amino acid oxidase. Physiological Chemistry and Physics 14(3): 193-199
Bounias, M.; Pacheco, H. 1974: L-leucine and L-4-aza-leucine, allosteric effectors of alkaline phosphatasic activity of barley. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences. Serie D: Sciences Naturelles 279(8): 691-694
Landgraf, R.; Landgraf-Leurs, M.M.; Hörl, R. 1974: L-leucine and L-phenylalanine induced insulin release and the influence of D-glucose. Kinetic studies with the perfused rat pancreas. Diabetologia 10(5): 415-420
Knudsen, P.; Kofod, H.; Lernmark, A.; Hedeskov, C.J. 1983: L-leucine methyl ester stimulates insulin secretion and islet glutamate dehydrogenase. American Journal of Physiology 245(4): E338-E346
Haschemeyer, A.E. 1982: L-leucine transport in liver of Antarctic fish in vivo at 0 degrees C. American Journal of Physiology 242(3): R280-R284
Smith, M.J.; Beigelman, P.M. 1968: L-leucine-14C (UL) metabolism in isolated fat cells. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 129(2): 621-623
Chan, W.W. 1983: L-leucinthiol - a potent inhibitor of leucine aminopeptidase. Biochemical and Biophysical Research Communications 116(1): 297-302
Graff, G.L.; Brouet-Yager, M.; Kleiner, H. 1974: L-leucyl-and L-phenylalanyl-beta-naphthylamidase activities in the tissues of the sea mussel (Mytilus edulis L.). Comparative Biochemistry and Physiology. B Comparative Biochemistry 49(3): 381-386
Kleiner, H. 1966: L-leucyl-beta-naphthylamide hydrolase (LNAH) in normal pregnancy. Acta Clinica Belgica 21(2): 136-137
Kleiner, H.; Graff, G.L.; Mahler-Rabinovitch, A. 1971: L-leucyl-beta-naphthylamine hydrolase (LNAse) in the plasma and organs of pregnant and nonpregnant rats. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 165(6): 1475-1478
Jost, R.; Tun-Kyi, A.; Stoll, E.; Zuber, H. 1972: L-leucyl-sarcosyl-L-phenylalanine, synthesis and effect on aminopeptidases i and Ii from Bacillus stearothermophilus. Helvetica Chimica Acta 55(3): 1025-1030
Dilova, K.; Dimova, I.; Boiadzhieva, L.; Ganchev, K. 1984: L-lysine decarboxylase biosynthesis by Bacterium cadaveris in stab cultivation. Acta Microbiologica Bulgarica 15: 72-77
Kern, B.A.; Hendlin, D.; Inamine, E. 1980: L-lysine epsilon-aminotransferase involved in cephamycin C synthesis in Streptomyces lactamdurans. Antimicrobial Agents and ChemoTherapy 17(4): 679-685
Bárta, Z.; Kimlová, I.; Libický, A. 1968: L-lysine ethylester as a substrate for trypsin assay in Czechoslovak Pharmakopeia. Ceskoslovenska Farmacie 17(1): 7-11
Diwan, J.J.; Aram, J.P. 1974: L-lysine uptake by rat liver mitochondria. Dependence on L-lysine concentration, pH, and induced K+ flux. Biophysical Journal 14(10): 805-808
Smirnova, I.P.; Khaduev, S.K. 1984: L-lysine-alpha-oxidase activity of some Trichoderma species. Mikrobiologiia 53(1): 163-165
Cotzias, G.C.; Papavasiliou, P.S.; Mena, I. 1973: L-m-tyrosine and Parkinsonism. JAMA 223(1): 83
Jurtshuk, P.; Bednarz, A.J.; Zey, P.; Denton, C.H. 1969: L-malate oxidation by the electron transport fraction of Azotobacter vinelandii. Journal of Bacteriology 98(3): 1120-1127
Coto, E.O.; Castaneda, A.R.; Caffarena, J.M.; Deverall, P.B.; Cabrera, A.; Jimenez, M.Q. 1982: L-malposed great arteries with situs solitus and concordant atrioventricular connection. Journal of Cardiovascular Surgery 23(4): 277-286
Kaczurba, E.; Hay, M. 1982: L-methioninase production by some gram-negative bacteria. Acta Microbiologica Polonica 31(2): 203-207
Verzár, F.; Strittmatter-Ackerschott 1973: L-methionine as regulator of collagen tension. Experientia 29(8): 1035-1036
Arp, D.J.; Zumft, W.G. 1983: L-methionine-SR-sulfoximine as a probe for the role of glutamine synthetase in nitrogenase switch-off by ammonia and glutamine in Rhodopseudomonas palustris. Archives of Microbiology 134(1): 17-22
Androsov, V.V.; Levashev, V.S. 1974: L-mutants of Escherichia coli and Salmonella, obtained by exposure to N-nitroso-N-methylurea. Doklady Akademii Nauk SSSR 216(1): 202-204
Wong, Y.H.; Mauck, L.A.; Sherman, W.R. 1982: L-myo-Inositol-1-phosphate synthase from bovine testis. Methods in Enzymology 90 Pt E: 309-314
Mauck, L.A.; Wong, Y.H.; Sherman, W.R. 1980: L-myo-Inositol-1-phosphate synthase from bovine testis: purification to homogeneity and partial characterization. Biochemistry 19(15): 3623-3629
Rondouin, G.; Bockaert, J.; Lerner-Natoli, M. 1993: L-nitroarginine, an inhibitor of NO synthase, dramatically worsens limbic epilepsy in rats. Neuroreport 4(10): 1187-1190
Fåhraeus, L.; Larsson-Cohn, U.; Wallentin, L. 1983: L-norgestrel and progesterone have different influences on plasma lipoproteins. European Journal of Clinical Investigation 13(6): 447-453
Inoue, D.; Pappano, A.J. 1983: L-palmitylcarnitine and calcium ions act similarly on excitatory ionic currents in avian ventricular muscle. Circulation Research 52(6): 625-634
Godzeski, C.; Brier, G.; Glenn, W. 1968: L-phase bacteria in human heart tissue. Life Sciences 7(2): 107-112
Gnarpe, H. 1971: L-phase bacteria in urinary tract infections. Lakartidningen 68(39): 4361-4364
Clasener, H.A. 1970: L-phase colonies cultured from mice infected with group a hemolytic streptococci. Zentralblatt für Bakteriologie Parasitenkunde Infektionskrankheiten und Hygiene. 1. Abt. Medizinisch-Hygienische Bakteriologie Virusforschung und Parasitologie. Originale 214(3): 329-330
Maekawa, S.; Hayashi, T.T. 1973: L-phase variants of group a hemolytic streptococci not requiring high osmolarity. Japanese Journal of Microbiology 17(3): 228-229
Kwan, C.Y.; Davis, R.C. 1981: L-phenylalanine induced changes of sulfhydryl reactivity in rabbit muscle pyruvate kinase. Canadian Journal of Biochemistry 59(2): 92-99
Ghosh, N.K.; Fishman, W.H. 1968: L-phenylalanine inhibiton of rat intestinal alkaline phosphatase: a homosteric phenomenon. Archives of Biochemistry and Biophysics 126(2): 700-706
Wapnir, R.A.; Lifshitz, F. 1974: L-phenylalanine interactions with structurally related substances at the intestinal mucosa. Biochemical Medicine 11(4): 370-375
Furner, R.L.; Brown, R.K. 1980: L-phenylalanine mustard (L-PAM): the first 25 years. Cancer Treatment Reports 64(4-5): 559-574
Sutow, W.W.; Sullivan, M.P.; Wilbur, J.R.; Vietti, T.J.; Kaizer, H.; Nagamoto, A. 1971: L-phenylalanine mustard (NSC-8806) administration in osteogenic sarcoma: an evaluation of dosage schedules. Cancer ChemoTherapy Reports 55(2): 151-157
Brox, L.W.; Gowans, B.; Belch, A. 1980: L-phenylalanine mustard (melphalan) uptake and cross-linking in the RPMi 6410 human lymphoblastoid cell line. Cancer Research 40(4): 1169-1172
Tormey, D.C.; Bull, J.M.; Lipman, M.L. 1980: L-phenylalanine mustard, doxorubicin, and vincristine in advanced breast cancer: a pilot study. Cancer Treatment Reports 64(8-9): 1015-1016
Holler, E.; Kosakowski, H.M. 1973: L-phenylalanyl-tRNA synthetase of E. coli. Active site specific binding of 2-p-toluidinylnaphthalene-6-sulfonate. Biochemical and Biophysical Research Communications 54(4): 1532-1539
Hanke, T.; Bartmann, P.; Hennecke, H.; Kosakowski, H.M.; Jaenicke, R.; Holler, E.; Böck, A. 1974: L-phenylalanyl-tRNA synthetase of Escherichia coli K-10. a reinvestigation of molecular weight and subunit structure. European Journal of Biochemistry 43(3): 601-607
Coombs, W.H. 1968: L-plate radiography. Radiography 34(405): 189-201
Bignozzi, L. 1973: L-polamivet in surgery in horses. Folia Veterinaria Latina 3(2): 343-349
Nakamura, T.; Teramoto, H.; Tomita, Y.; Ichihara, A. 1984: L-proline is an essential amino acid for hepatocyte growth in culture. Biochemical and Biophysical Research Communications 122(3): 884-891
Stănescu, V.; Florea, I.; Ionescu, V.; Dinulescu, E.; Stănescu, R. 1968: L-proline loading test in growth disturbances. Helvetica Paediatrica Acta 23(2): 147-153
Boyd, C.A.; Lund, E.K. 1981: L-proline transport by brush border membrane vesicles prepared from human placenta. Journal of Physiology 315: 9-19
Hearn, W.R.; Worthington, R.E. 1967: L-proline-N-oxalic anhydride. Journal of Organic Chemistry 32(12): 4072-4074
North, R.B.; Harik, S.I.; Snyder, S.H. 1973: L-prolyl-L-leucyl-glycinamide (PLG): influences on locomotor and stereotyped behavior of cats. Brain Research 63: 435-439
Rieke, G.K.; Scarfe, A.D.; Hunter, J.F. 1984: L-pyroglutamate: an alternate neurotoxin for a rodent model of Huntington's disease. Brain Research Bulletin 13(3): 443-456
Wolfersberger, M.G.; Tabachnick, J.; Finkelstein, B.S.; Levin, M. 1973: L-pyrrolidone carboxylic acid content in mammalian epidermis and other tissues. Journal of Investigative Dermatology 60(5): 278-281
Daisuke, T.; Kunio, F. 1980: L-pyrrolidone carboxylyl peptidase. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 25(6): 490-499
Chiu, T.H.; Feingold, D.S. 1969: L-rhamnulose 1-phosphate aldolase from Escherichia coli. Crystallization and properties. Biochemistry 8(1): 98-108
Salo, W.L.; Fossitt, D.D.; Bevill, R.D.; Kirkwood, S.; Wood, W. 1972: L-ribulose 5-phosphate 4-epimerase from Aerobacter aerogenes. Kinetic isotope effect with tritiated substrate. Journal of Biological Chemistry 247(10): 3098-3100
Allen, B.L.; Ferguson, R.L. 1982: L-rod instrumentation for scoliosis in cerebral palsy. Journal of Pediatric Orthopedics 2(1): 87-96
Holcomb, T.M.; Haggard, M.E.; Berry, D.H.; Sullivan, M.P.; Watkins, W.L.; Windmiller, J. 1965: L-sarcolysin (NSC-8806) therapy for acute leukemia in children. Cancer ChemoTherapy Reports 48: 45-48
Fernbach, D.J.; Haddy, T.B.; Holcomb, T.M.; Stuckey, W.J.; Watkins, W.L. 1968: L-sarcolysin (NSC-8806) therapy for children with metastatic neuroblastoma. Cancer ChemoTherapy Reports 52(2): 293-296
Simon, S.I.; Burns, A.R.; Taylor, A.D.; Gopalan, P.K.; Lynam, E.B.; Sklar, L.A.; Smith, C.W. 1995: L-selectin (CD62L) cross-linking signals neutrophil adhesive functions via the Mac-1 (CD11b/CD18) beta 2-integrin. Journal of Immunology 155(3): 1502-1514
Michie, S.A.; Streeter, P.R.; Butcher, E.C.; Rouse, R.V. 1995: L-selectin and alpha 4 beta 7 integrin homing receptor pathways mediate peripheral lymphocyte traffic to AKR mouse hyperplastic thymus. American Journal of Pathology 147(2): 412-421
Watson, S.R. 1993: L-selectin-IgG chimera--in vitro and in vivo. Agents and Actions. Supplements 41: 103-109
Tanizawa, K.; Miles, E.W. 1983: L-serine binds to arginine-148 of the beta 2 subunit of Escherichia coli tryptophan synthase. Biochemistry 22(15): 3594-3603
Alföldi, L.; Raskó, I.; Kerekes, E. 1968: L-serine deaminase of Escherichia coli. Journal of Bacteriology 96(5): 1512-1518
Newman, E.B.; Walker, C. 1982: L-serine degradation in Escherichia coli K-12: a combination of L-serine, glycine, and leucine used as a source of carbon. Journal of Bacteriology 151(2): 777-782
Newman, E.B.; Malik, N.; Walker, C. 1982: L-serine degradation in Escherichia coli K-12: directly isolated ssd mutants and their intragenic revertants. Journal of Bacteriology 150(2): 710-715
Simon, D.; Hoshino, J.; Kröger, H. 1973: L-serine dehydratase from rat liver. Purification and some properties. Biochimica et Biophysica Acta 321(1): 361-368
Lee, L.P.; Bernstein, I.A. 1968: L-serine dehydratase, DL-threonine aldolase, and D-glucuronate reductase in serum. Effects following experimental liver and kidney damage in the rat. Archives of Environmental Health 16(5): 615-618
Pogliani, L.; Ziessow, D. 1983: L-serine tripeptides: Ac-Ser-Gly, Ala-Ser-Gly and Gly-Ser-Phe. International Journal of Peptide and Protein Research 22(2): 148-153
Min, B.; Chung, H.K.; Lee, J.S.; Ha, W.C. 1972: L-shaped osteotomy, performed for prognathism and right displacement with open bite of mandible. Taehan Ch'ikkwa Uisa Hyophoe Chi 10(6): 373-377
Willott, G.M. 1972: L-tartrate inhibitable acid phosphatase in semen and vaginal secretions. Journal - Forensic Science Society 12(2): 363-366
Rembold, H.; Heinz, G. 1971: L-threo-Neopterin, the major pterin in Escherichia coli B. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 352(9): 1271-1272
Aleo, M.F.; Casella, A.; Marinello, E. 1981: L-threonine deaminase in gluconeogenesis. Bollettino della Societa Italiana di Biologia Sperimentale 57(17): 1739-1745
Antia, N.J.; Kripps, R.S.; Desai, I.D. 1972: L-threonine deaminase in marine planktonic algae. 3. Stimulation of activity by monovalent inorganic cations and diverse effects from other ions. Archiv für Mikrobiologie 85(4): 341-354
Feldberg, R.S.; Datta, P. 1971: L-threonine deaminase of Rhodospirillum rubrum. Purification and characterization. European Journal of Biochemistry 21(3): 438-446
Nefelova, M.V.; Natal'ina, V.M.; Shaposhnikov, G.L. 1973: L-threonine dehydratase in the producer of aurantin Actinomyces sp. 2. Mikrobiologiia 42(2): 208-212
Loseva, L.P.; Liubimov, V.I.; Kagan, Z.S.; Kretovich, V.L. 1968: L-threonine dehydratase of Azotobacter vinelandii. Doklady Akademii Nauk SSSR 181(4): 997-1000
Boylan, S.A.; Dekker, E.E. 1981: L-threonine dehydrogenase. Purification and properties of the homogeneous enzyme from Escherichia coli K-12. Journal of Biological Chemistry 256(4): 1809-1815
Stone, E.; Leiter, L.A.; Lambert, J.R.; Silverberg, J.D.; Jeejeebhoy, K.N.; Burrow, G.N. 1984: L-thyroxine absorption in patients with short bowel. Journal of Clinical Endocrinology and Metabolism 59(1): 139-141
Obregon, M.J.; Mallol, J.; Pastor, R.; Morreale de Escobar, G.; Escobar del Rey, F. 1984: L-thyroxine and 3,5,3'-triiodo-L-thyronine in rat embryos before onset of fetal thyroid function. Endocrinology 114(1): 305-307
Rao, G.S.; Rao, M.L. 1983: L-thyroxine enters the rat liver cell by simple diffusion. Journal of Endocrinology 97(2): 277-282
Leibow, D. 1983: L-thyroxine for rapid-cycling bipolar illness. American Journal of Psychiatry 140(9): 1255
Geatti, O.; Barkan, A.; Turrin, D.; Orsolon, P.G.; Shapiro, B. 1993: L-thyroxine malabsorption due to the injection of herbal remedies. Thyroidology 5(3): 97-102
Shapiro, B.; Gross, M.D.; Geatti, O. 1993: L-thyroxine overdose: a case of marked, severe, prolonged, excess ingestion and review of the literature. Thyroidology 5(2): 61-66
González Barranco, J.; Rull, J.A.; Lozano Castañeda, O. 1974: L-thyroxine propylhexedrine in the treatment of obesity. Crossed double blind study. La Prensa Medica Mexicana 39(5-6): 298-299
Albright, F.; Schroepfer, G.J. 1970: L-trans-2,3-epoxysuccinate. a new substrate for fumarase. Biochemical and Biophysical Research Communications 40(3): 661-666
Albright, F.; Schroepfer, G.J. 1971: L-trans-2,3-epoxysuccinic acid. a new substrate for fumarase. Journal of Biological Chemistry 246(5): 1350-1357
Barrett, A.J.; Kembhavi, A.A.; Brown, M.A.; Kirschke, H.; Knight, C.G.; Tamai, M.; Hanada, K. 1982: L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochemical Journal 201(1): 189-198
Kochemasova, Z.N.; Dykhno, M.M.; Kassirskaia, N.G.; Bakanova, D.I. 1969: L-transformation of Mycobacterium tuberculosis as one of the sources of formation of drug resistant strains. Vestnik Akademii Meditsinskikh Nauk SSSR 24(5): 91-94
Kochemasova, Z.N.; Dykhno, M.M.; Prozorovskiĭ, S.V.; Kassirskaia, N.G.; Bakanova, D.I. 1968: L-transformation of Mycobacterium tuberculosis strains isolated from patients treated with antibiotics. Problemy Tuberkuleza 46(8): 64-67
Dorozhkova, I.R.; Zemskova, Z.S.; Krudu, V.N. 1995: L-transformation of mycobacteria in the light of current epidemiological situation of tuberculosis in the world. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 7: 30-33
Khomenko, A.G.; Karachunskiĭ, M.A.; Dorozhkova, I.R.; Chukanov, V.I.; Balta, I.E. 1980: L-transformation of the mycobacterial population in the process of treating patients with newly detected destructive pulmonary tuberculosis. Problemy Tuberkuleza 2: 18-23
Fedorova, Z.F. 1982: L-transforming effect of furazolidone on Shigella flexneri cells. Antibiotiki 27(7): 527-530
Pompei, A.; Traverso, E.; Ronzitti, M. 1969: L-triiodothyronine in the prevention and therapy of arteriosclerosis. Archivio "e. Maragliano" di Patologia E Clinica 25(6): 519-536
Matsumura, M.; Osada, K.; Aiba, S. 1984: L-tryptophan 2,3-dioxygenase of a moderate thermophile, Bacillus brevis. Purification, properties and a substrate-mediated stabilization of the quaternary structure. Biochimica et Biophysica Acta 786(1-2): 9-17
Anonymous 1972: L-tryptophan and depressive illness. Drug and Therapeutics Bulletin 10(19): 75-76
Sethi, R.F. 1974: L-tryptophan and inflammation. Indian Journal of Physiology and Pharmacology 18(4): 355-357
Sanders, R.B.; Parekh, N.B. 1970: L-tryptophan antagonism of epinephrine-induced hyperglycemia in rats. Pharmacology 3(5): 305-314
Hartmann, E. 1971: L-tryptophan as a physiological hypnotic. Lancet 1(7703): 807
Carroll, B.J.; Dodge, J. 1971: L-tryptophan as an antidepressant. Lancet 1(7705): 915
Chagoya, G.; Hernández, J. 1983: L-tryptophan during gestation induces an increase in brain tryptophan 5-hydroxylase activity and serotonin synthesis. Proceedings of the Western Pharmacology Society 26: 369-372
Murphy, D.L.; Baker, M.; Goodwin, F.K.; Miller, H.; Kotin, J.; Bunney, W.E. 1974: L-tryptophan in affective disorders: indoleamine changes and differential clinical effects. Psychopharmacologia 34(1): 11-20
Prange, A.J.; Wilson, I.C.; Lynn, C.W.; Alltop, L.B.; Stikeleather, R.A. 1974: L-tryptophan in mania. Contribution to a permissive hypothesis of affective disorders. Archives of General Psychiatry 30(1): 56-62
Schmidt, H.S. 1983: L-tryptophan in the treatment of impaired respiration in sleep. Bulletin Europeen de Physiopathologie Respiratoire 19(6): 625-629
Cihak, A.; Lamar, C.; Pitot, H.C. 1973: L-tryptophan inhibition of tyrosine aminotransferase degradation in rat liver in vivo. Archives of Biochemistry and Biophysics 156(1): 188-194
Peters, J.C.; Bellissimo, D.B.; Harper, A.E. 1984: L-tryptophan injection fails to alter nutrient selection by rats. Physiology and Behavior 32(2): 253-259
Vassella, F.; Colombo, J.P.; Humbel, R.; Rossi, E. 1968: L-tryptophan metabolism in phenylketonuria. Helvetica Paediatrica Acta 23(1): 22-36
Birkmayer, W.; Neumayer, E. 1972: L-tryptophan therapy of DOPA psychoses. Der Nervenarzt 43(2): 76-78
Broadhurst, A.D. 1970: L-tryptophan verses E.C.T. Lancet 1(7661): 1392-1393
Cocheme, M.A. 1970: L-tryptophan versus E.C.T. Lancet 1(7661): 1392
Marcus, S.L. 1974: L-tryptophan-agarose in the purification of an anthranilate synthetase complex. Methods in Enzymology 34: 389-394
Leino, E.; MacDonald, E.; Airaksinen, M.M.; Riekkinen, P.J.; Salo, H. 1981: L-tryptophan-carbidopa trial in patients with long-standing progressive myoclonus epilepsy. Acta Neurologica Scandinavica 64(2): 132-141
Herken, H.; Weber, H.J. 1971: L-tryptophan-induced increase of renal sodium reabsorption. Naunyn-Schmiedebergs Archiv für Pharmakologie 271(2): 206-210
Lin, C.W.; Sie, H.G.; Fishman, W.H. 1971: L-tryptophan. a non-allosteric organ-specific uncompetitive inhibitor of human placental alkaline phosphatase. Biochemical Journal 124(3): 509-516
Litman, D.A.; Correia, M.A. 1983: L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?. Science 222(4627): 1031-1033
Francesconi, R.P.; Mager, M. 1974: L-tryptophan: effects on body temperature in rats. American Journal of Physiology 227(2): 402-405
Spinweber, C.L.; Ursin, R.; Hilbert, R.P.; Hilderbrand, R.L. 1983: L-tryptophan: effects on daytime sleep latency and the waking EEG. Electroencephalography and Clinical Neurophysiology 55(6): 652-661
Martinez-Piñero, M.G.; Vargas, M.L.; Milanés, M.V. 1993: L-type Ca2+ channel ligands modulate morphine effects on the hypothalamus-pituitary-adrenocortical axis in rats. European Journal of Pharmacology 232(2-3): 191-198
Spergel, D.J.; Krsmanovic, L.Z.; Stojilkovic, S.S.; Catt, K.J. 1995: L-type Ca2+ channels mediate joint modulation by gamma-amino-butyric acid and glutamate of [Ca2+]i and neuropeptide secretion in immortalized gonadodropin-releasing hormone neurons. Neuroendocrinology 61(5): 499-508
Simmons, M.L.; Terman, G.W.; Gibbs, S.M.; Chavkin, C. 1995: L-type calcium channels mediate dynorphin neuropeptide release from dendrites but not axons of hippocampal granule cells. Neuron 14(6): 1265-1272
Christie, B.R.; Abraham, W.C. 1994: L-type voltage-sensitive calcium channel antagonists block heterosynaptic long-term depression in the dentate gyrus of anaesthetized rats. Neuroscience Letters 167(1-2): 41-45
Boels, P.J.; Coen, E.; Vanhoutte, P.M. 1982: L-tyrosine and adrenergic neuroeffector interaction in the canine saphenous vein. Archives Internationales de Pharmacodynamie et de Therapie 256(1): 155-156
Gallon, J.R.; Butt, V.S. 1971: L-tyrosine decarboxylase from barley roots. Biochemical Journal 123(2): 5P-6P
Bonilla, E. 1980: L-tyrosine hydroxylase activity in the rat brain after chronic oral administration of manganese chloride. Neurobehavioral Toxicology 2(1): 37-41
Goldberg, I.K. 1980: L-tyrosine in depression. Lancet 2(8190): 364-365
Pshirkov, S.Iu.; Boĭko, O.I.; Kiprianova, E.A.; Starovoĭtov, I.I. 1982: L-tyrosine transformation into L-dihydroxyphenylalanine by Pseudomonas cultures. Mikrobiologiia 51(2): 272-274
Pomerantz, S.H. 1969: L-tyrosine-3,5-3H assay for tyrosinase development in skin of newborn hamsters. Science 164(3881): 838-839
Wu, A.F.; Chargaff, E. 1969: L-uridine: synthesis and behavior as enzyme substrate. Proceedings of the National Academy of Sciences of the United States of America 63(4): 1222-1226
Cifuentes, B.; García, I.; Vicente, C. 1983: L-usnate-urease interactions: binding sites for polymerization. Zeitschrift für Naturforschung. Section C Biosciences 38(3-4): 273-276
García, I.; Cifuentes, B.; Vicente, C. 1980: L-usnate-urease interactions: binding sites for the ligand. Zeitschrift für Naturforschung. Section C Biosciences 35(11-12): 1098-1100
Grama, D.P. 1970: L-virus and potato gothic. Mikrobiolohichnyi Zhurnal 32(4): 516-518
Rivara Ruiz, G.; Dejo Bustios, G.; Alvarez Molteni, R. 1971: Cardiotonic effect of Cd 412 (Peruvosid) on normal humans and subjects with cardiac insufficiency. Revista Espanola de Cardiologia 24(2): 191-199
Leĭbson, L.G.; Orbeli, L.A. 1983: L. A. Orbeli and various aspects of evolutionary physiology. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 19(4): 322-332
Vakhrameeva, I.A.; Shepoval'nikov, A.N. 1983: L. A. Orbeli's concept of the development of higher nervous activity and modern child neurophysiology. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 19(5): 446-453
Panasiuk, A.; Chernyĭ, L.; Tarasevich, L.A. 1980: L. A. Tarasevich. Meditsinskaia Sestra 39(12): 58-59
Vasil'ev, K.G.; Gol'd, E.Iu.; Tarasevich, L.A. 1968: L. A. Tarasevich-epidemiologist (on his 100th anniversary). Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 45(10): 14-18
Anonymous 1966: L. A. fluoridation proposal killed by City Council vote. Journal-SouthernCaliforniaDentalAssociation 34(12): 533
Lerner, I.M.; Dunn, L.C. 1974: L. C. Dunn (1893-1974) and poultry genetics: a brief memoir. Journal of Heredity 65(3): 185-186
Hammond, B.F. 1969: L. Casei, Hero. Medical Affairs 26: 28-29
Downey, H.K.; Moss, L.C. 1974: L. Conner Moss, MD. Transactions of the American Ophthalmological Society 72: 13-14
Prudhon, C. 1967: L. D. 3300 by mouth. Therapeutic trial in dental practice. L' Information Dentaire 49(5): 447-449
Fischer, T. 1980: L. Dopa. Soins; la Revue de Reference Infirmiere 25(19): 33-34
Norbury, L.E. 1967: L. E. C. Norbury. British Medical Journal 4(5575): 362
Desjardins, E.; Desjardins, L.E. 1969: L. E. Desjardins (1837-1919): one of the pioneers of ophthalmology in French Canada. Canadian Journal of Surgery. Journal Canadien de Chirurgie 12(2): 165-171
Houghton, L.E. 1974: L. E. Houghton. British Medical Journal 1(5899): 164
Jones, B.R. 1974: Laboratory tests for chlamydial infection. their role in epidemiological studies of trachoma and its control. British Journal of Ophthalmology 58(4): 438-454
Callaerts, J.; Demol, R.; Figoureux, J.; Kock, E.; Huyghebaert, G. 1973: Clinical study of a new oral contraceptive: ovostat. Bruxelles Medical 53(7): 409-418
MacRoberts, M.H.; Bailey, L.H.; Mendel, G. 1984: L. H. Bailey's citations to Gregor Mendel. Journal of Heredity 75(6): 500-501
Nacef, K.; Chaouch, M.Ali.; Bouriga, R.; Khalifa, M.Ben.; Chaouch, A.; Ghannouchi, M.; Boudokhane, M. 2019: A Case Report of Abdominal Desmoplastic Small Round Cell Tumor in a Young Tunisian Woman. Journal of Gastrointestinal Cancer 50(3): 568-571
Wilbur, D.L.; Garland, L.H. 1967: L. Henry Garland, 1903-1966. American Journal of Roentgenology Radium Therapy and Nuclear Medicine 100(2): 482-484
Wells, R.L.; Whitney, L.H. 1966: L. Holland Whitney, MD. Biographical sketch. Archives of Environmental Health 13(3): 277
Medved', L.I. 1965: L. I. Medved'. (On his 60th birthday). Gigiena i Sanitariia 30(7): 128-129
Tiuliandin, A.D.; Popov, L.K. 1981: L. Kh. Popov, organizer of the Soviet Red Cross (on the centenary of his birth). Meditsinskaia Sestra 40(9): 59-60
Petrov, B.D.; Popov, L.K. 1965: L. Kh. Popov--the first chief of the Soviet Red Cross. Sovetskoe Zdravookhranenie 24(11): 63-66
Pitskhelauri, G.Z.; Kornaro, L. 1969: L. Kornaro and his treatise on the temperate life. Voprosy Pitaniia 28(4): 86-88
Christoffersen, J.C.; Jacobson, L.L. 1980: L. L. Jacobson (1783-1843). Investigative Urology 18(3): 227
Walker, L.G.; Staton, L.L. 1984: L. L. Staton, M.D., and the first successful gastrostomy in America. Surgery Gynecology and Obstetrics 158(4): 387-388
Gol'dshteĭn, L.M. 1980: L. M. Gol'dshteĭn. Vestnik Dermatologii i Venerologii 1980(2): 75
Rusavskaia, T.L.; Gorovits-Vlasova, L.M. 1974: L. M. Gorovits-Vlasova as one of the founders of Soviet sanitary microbiology. Gigiena i Sanitariia 1974(4): 58-59
Monheim, L.M. 1971: L. M. Monheim, famed anesthesiologist, dies. Journal of the American Dental Association 83(6): 1263-1264
Ramphul, K.; Mejias, S.G.; Ramphul-Sicharam, Y.; Hamid, E.; Sonaye, R. 2018: A Case Report of a Child with Bell's Palsy. Cureus 10(4): E2408
Emery, J.L.; MacKenzie, N. 1973: Medullo-cervical dislocation deformity (Chiari Ii deformity) related to neurospinal dysraphism (meningomyelocele). Brain: a Journal of Neurology 96(1): 155-162
Fourman, L.P. 1968: L. P. R. Fourman, D.SC., M.D., F.R.C.P. British Medical Journal 4(5624): 192-193
Mysh, V.G.; Dragstedt, L.R. 1983: L. R. Dragstedt (contribution to the theory of the pathogenesis and treatment of peptic ulcer). Khirurgiia 1983(7): 140-141
Tomilin, V.V.; Berezhnoĭ, R.V.; Sergeev, S.N. 1980: Possibilities and prospects for using histoenzymatic methods in forensic medicine. Sudebno-Meditsinskaia Ekspertiza 23(2): 8-12
Jirka, F.J.; Fruin, L.T. 1973: L. T. Fruin, M.D.--in memorian. Illinois Medical Journal 141(3): 258
Pearsall, S.G.; Wilshusen, W. 1968: L. the disposal of chemical and radioactive waste. Journal of Chemical Education 45(8 Suppl): a599+
Pearsall, S.G.; Wilshusen, W. 1968: L. the disposal of chemical and radioactive waste. two. Journal of Chemical Education 45(9 Suppl): a677+
Funshteĭn, L.V. 1971: L. V. Funshteĭn. Meditsinskaia Radiologiia 16(6): 94-95
Favorova, L.A. 1984: L. V. Gromashevskiĭ's theory and the problem of eradicating infectious diseases. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1984(7): 119-123
Beliakov, V.D. 1984: L. V. Gromashevskiĭ's theory of the epidemic process and the development of this theory today. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 1984(7): 115-118
Morgunov, I.N.; Gromashevskiĭ, L.V. 1968: L. V. Gromashevskiĭ--scientist, pedagog and social worker. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 45(6): 3-6
Hale LW|HALE, L.W. 1974: L. W. Hale M.D., F.R.C.P. British Medical Journal 4(5939): 294
Dost, F.H.; Weingärtner, L. 1970: L. Weingärtner on his 60th birthday. Archiv für Kinderheilkunde 181(3): 209-210
Nathan, H.; Zukschwerdt, L. 1974: L. Zukschwerdt. Die Medizinische Welt 25(19): 871-873
Dimitriu, S.; Mihalache, D.; Turcu, T.; Bordei, P.; Ulianov, M.; Luca, V.; Apostol, A.; Obreja, E. 1984: L. monocytogenes septicemia in a newborn and an older infant. Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 88(2): 279-282
Parsadanian, R.; Lalaian, A.; Oganesian, L.A. 1970: L.A. Oganesian--prominent medical historian. Sovetskoe Zdravookhranenie 29(9): 95
Hagen, J.O.; McCarthy, F.M. 1969: General anesthesia for the ambulatory patient: the anesthetic team. Journal - Southern California Dental Association 37(6): 244-247
Natoli, G.; Natoli, V.; Lapi, A.S.; Mancini, G.; Renzulli, F. 1969: L.A.P. isoenzymes in neonatal hepatitis and biliary atresia. Lancet 1(7587): 209
Anonymous 1970: L.A.T.S. Lancet 2(7668): 349-350
Mouriz, J. 1970: L.A.T.S. Etiological factor of Basedow-Graves' disease. Revista Iberica de Endocrinologia 17(102): 477-489
Letonturier, P.; Tourneur, R.; Sénécal, P. 1974: L.A.T.S. activity during hyperthyroidism. Apropos of 143 cases of Basedow's disease. Annales de Medecine Interne 125(5): 463-467
Giumanini, A.G. 1967: L.C.A.O.-M.O. calculations on isomeric methyleneindenes. Bollettino Chimico Farmaceutico 106(8): 515-520
Chapman, R.L.; Modell, J.H.; Ruiz, B.C.; Calderwood, H.W.; Hood, C.I.; Graves, S.A. 1973: Effect of continuous positive-pressure ventilation and steroids on aspiration of hydrochloric acid (pH 1.8) in dogs. Anesthesia and Analgesia 53(4): 556-562
Clemens, K.M. 1971: Circuit riders or competency builders?. Ohio Dental Journal 45(5): 311
Alvarez, L.; De Miguel, E.; Calvet, E.; Ramón, F. 1980: L.D.H. and isoenzymes in C.S.F. of children with neurological diseases. Anales Espanoles de Pediatria 13(2): 133-150
Schleicher, E.M. 1968: L.E. cells after oral contraceptives. Lancet 1(7546): 821-822
Harth, M. 1968: L.E. cells and positive direct Coombs' test induced by methyldopa. Canadian Medical Association Journal 99(6): 277-280
Leahy, B. 1973: L.E.A. grants. Manchester Medical Gazette 52(3): 74-75
Evans, L.F. 1973: L.F. Evans. British Medical Journal 2(5858): 123
Viduta, V.K.; Lenevich, L.F. 1970: L.F. Lenevich--1st holder of the Red Banner of Labor Order among physicians. Sovetskoe Zdravookhranenie 29(9): 87-90
Tubiana, M. 1982: L.H. Gray Medal lecture: cell kinetics and radiation oncology. International Journal of Radiation Oncology Biology Physics 8(9): 1471-1489
van Emde Boas, C.; Levie, L.H. 1971: L.H. Levie, 40 years a physician. Nederlands Tijdschrift Voor Geneeskunde 115(48): 2034-2035
Johnston, R.N.; McNeill, R.S.; Smith, D.H.; Dempster, M.B.; Nairn, J.R.; Purvis, M.S.; Watson, J.M.; Ward, F.G. 1969: Five-year winter chemoprophylaxis for chronic bronchitis. British Medical Journal 4(5678): 265-269
Pull, C.B.; Pull, M.C.; Pichot, P. 1984: L.I.C.E.T.-D 100: a new approach to the diagnosis of depression. Annales Medico-Psychologiques 142(6): 831-847
Harris, L.J. 1973: L.J. Harris. British Medical Journal 3(5870): 54
Herman, E.; Gliński, L.K. 1967: L.K. Gliński's research on the role of the anterior pituitary lobe. Neuropatologia Polska 5(2): 149-157
Déodati, F.; Labro, J.B.; Arné, J.L. 1972: L.M. 192 in ophthalmologic therapy. Bulletin des Societes d'Ophtalmologie de France 72(7): 763
FitzGerald, L.M. 1968: L.M. FitzGerald receives University of Iowa award. Journal of the American Dental Association 77(1): 58
FitzGerald, L.M. 1971: L.M. FitzGerald, former ASOS, ADA President, dies at 73. Journal of Oral Surgery 29(10): 751
Bondar', Z.A.; Berezina, L.V.; Feklisova, M.E. 1971: Methods of increasing the efficacy of dispensary care of patients with gastrics and duodenal ulcer under medical center conditions. Terapevticheskii Arkhiv 43(6): 3-7
Dohnány, L.; Tolstoĭ, L.N. 1982: L.N. Tolstoi on public health. Orvosi Hetilap 123(32): 1985-1988
Little, D.E. 1966: L.P.N. Amendment crucial to meet state nursing needs. Washington State Journal of Nursing 38(6): 2
Mason, M. 1971: L.P.N. as head of central service. Journal of Practical Nursing 21(1): 35-37
Kuz'min, M.K.; Vasilevskaia, O.V.; Bogolepova, L.S. 1970: L.S. Bogolepova--one of the 1st organizers of Soviet public health in the Khamovnik (Lenin) region of Moscow (on her 80th birthday). Sovetskaia Meditsina 33(2): 150-151
Czeizel, E.; Penrose, L.S. 1972: L.S. Penrose. Orvosi Hetilap 113(32): 1931-1933
Martini, M.; Daoud, A. 1968: Treatment of chronic osteitis of the calcaneum with calcanectomy. Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur 57(5): 415-419
Jacquelin, A. 1967: Attempt at a philosophy of contemporary therapy. Semaine Therapeutique 43(1): 7-15
Williams, L.N. 1969: L.S.D. and manslaughter. Lancet 2(7615): 332
Kilbourn, J.P. 1970: Infection in cystic fibrosis. Lancet 2(7678): 878-879
Rosenberg, C.M.; Eldred, B. 1968: L.S.D. psychosis. Medical Journal of Australia 1(4): 129-131
Hertz, M. 1968: L.S.D. stress and learning. Acta Psychiatrica Scandinavica. Supplementum 203: 201-204
Warnes, H. 1966: L.S.D., gloomy initials. Caridad Ciencia y Arte 4(13): 14-16
Blanc, W.A.; Mattison, D.R.; Kane, R.; Chauthan, P. 1971: L.S.D., intrauterine amputations, and amniotic-band syndrome. Lancet 2(7716): 158-159
Smart, R.D. 1968: L.S.D....problems and promise. Canadian Journal of Psychiatric Nursing 9(9): 5-12
Ledger, J.L. 1967: L.S.D.; a review. Manitoba Medical Review 47(7): 399-402
Shory, N.L. 1969: L.S.U. students survey opinions on dental health. Journal of the Louisiana Dental Association 27(1): 6-7
Kammerer, T.; Singer, L.; Sichel, J.P.; Gurfein, L.; Wysoki, V.; Rémy, R. 1967: L.W. 2159 (Etumine): clinical and control experimentation by a new method for statistical exploitation using electronic computers. Annales Medico-Psychologiques 125(2): 290-296
Tzafettas, J.M.; Zurnatzi, V.; Papaloucas, A.C. 1983: L/S ratio, biochemical and clinical changes after ritodrine intravenous infusion. European Journal of Obstetrics Gynecology and Reproductive Biology 14(6): 357-363
Sang, E.; Panepinto, W.C.; Kissin, B. 1973: L0w dose methadone to abstinence in a maternity-family care program. Proceedings. National Conference on Methadone Treatment 2: 1165-1171
Agarwal, M.B. 1994: L1 arthropathy syndrome. Journal of the Association of Physicians of India 42(11): 929-930
Gaetjens, E.C.; Chen, P.; Broome, J.D. 1984: L1210(A) mouse lymphoma cells depleted of glutathione with L-buthionine-S-R-sulfoximine proliferate in tissue culture. Biochemical and Biophysical Research Communications 123(2): 626-632
Fineschi, G. 1971: L2 and L1 radicular syndromes caused by disk hernia. 1st anatomo-clinical and diagnostic contribution. La Chirurgia Degli Organi di Movimento 60(1): 15-26
Shevach, E.M.; Ellman, L.; Davie, J.M.; Green, I. 1972: L2C Guinea pig lymphatic leukemia: a "B" cell leukemia. Blood 39(1): 1-12
Ellman, L.; Green, I. 1971: L2C guinea pig leukemia: immunoprotection and immunotherapy. Cancer 28(3): 647-654
Sarma, P.S.; Ueberhorst, P.J.; Zeve, V.; Whang-Peng, J.; Huebner, R. 1970: L2C/NB guinea pig leukemia: failure to demonstrate transmissible leukemogenic virus. Bibliotheca Haematologica 36: 574-577
Strausfeld, N.J.; Campos-Ortega, J.A. 1973: L3, the 3rd 2nd order neuron of the 1st visual ganglion in the "neural superposition" eye of Musca domestica. Zeitschrift für Zellforschung und mikroskopische Anatomie 139(3): 397-403
Dubeaux, P.; Glowinski, J.; Robine, D.; Niset, D.; Delafolie, A. 1994: L4 and L5 double nerve root pain following percutaneous nucleotomy at the L4-L5 level. Revue du Rhumatisme 61(6): 475-476
Kreitz, B.G.; Côté, P.; Cassidy, J.D. 1995: L5 vertebral compression fracture: a series of five cases. Journal of Manipulative and Physiological Therapeutics 18(2): 91-97
Zayer, M. 1982: L5-spondylolisthesis increases with advancing age usually more in men than in women. Lakartidningen 79(49): 4645-4646
Summers, W.P.; Handschumacher, R.E. 1971: L5178Y asparagine-dependent cells and independent clonal sublines. Toxicity of 5-diazo-4-oxo-L-norvaline. Biochemical Pharmacology 20(9): 2213-2220
Rascol, A.; Clanet, M.; Montastruc, J.L.; Delage, W.; Guiraud-Chaumeil, B. 1981: L5H tryptophan in the cerebellar syndrome treatment. Biomedicine / 35(4): 112-113
Fujita, T. 1969: LA-012: a new local anesthetic agent. Anesthesia and Analgesia 48(1): 31-34
Alvarez, J.R. 1984: LA-LV bypass for mitral stenosis. Annals of Thoracic Surgery 38(1): 90-91
Tammelleo, A.D. 1995: LA: E.R. treatment delayed 2 1/2 hours: delay not proximate cause of death. Regan Report on Nursing Law 36(3): 3
Tammelleo, A.D. 1984: LA: pregnant RN's back injury: Workmen's Comp. NY: bathroom incident: LPN negligent. Regan Report on Nursing Law 25(2): 3
Resnick, R.B.; Washton, A.M.; Garwood, J.; Perzel, J. 1982: LAAM instead of take-home methadone. Nida Research Monograph 41: 473-475
Toren, E.C.; Carey, R.N.; Sherry, A.E.; Davis, J.E. 1972: LABTRAN--a language and system for programming chemical experiments. Analytical Chemistry 44(2): 339-343
Widman, B. 1966: LAC-43 (Marcaine)--a new local anaesthetic. Acta Anaesthesiologica Scandinavica. Supplementum 25: 59-66
Ekblom, L.; Widman, B. 1966: LAC-43 and tetracaine in spinal anaesthesia. a controlled clinical study. Acta Anaesthesiologica Scandinavica. Supplementum 23: 419-425
Saba, G.; Mosca, A. 1968: LAC-43 in sacral epidural administration in anorectal surgery. Minerva Anestesiologica 34(4): 545-547
Caminiti, G. 1968: LAC-43 in segmentary peridural anesthesia and antalgic therapy determined by local infiltrations. Minerva Anestesiologica 34(4): 501-502
Rossano, C. 1968: LAC-43 or Marcaine in antalgic therapy. Minerva Anestesiologica 34(4): 542-544
Lind, B. 1965: LAC-43, a new long-acting local anesthetic. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 85(21): 1613-1615
Korkeila, J. 1966: LAC-43--clinical experiences with a new long-acting local anaesthetic agent in epidural anaesthesia. Acta Anaesthesiologica Scandinavica. Supplementum 23: 453-461
Zakirov, N.A.; Abidov, A.A.; Kalinina, E.F. 1969: LAC-mutants of pathogenic E. coli serotypes. Biulleten' Eksperimental'noi Biologii i Meditsiny 68(12): 89-90
Vickers, M. 1995: LACTNET--a needed communication. Journal of Human Lactation: Official Journal of International Lactation Consultant Association 11(3): 173
Rocci, M.L.; Jusko, W.J. 1983: LAGRAN program for area and moments in pharmacokinetic analysis. Computer Programs in Biomedicine 16(3): 203-216
Mayorga-Cortes, A.; Castellanos, A.; Myerburg, R.J. 1980: LAHB obscuring RBBB. Circulation 61(4): 866-867
Pham Manh Hung; Kalafut, F.; Novotná, L.; Koníková, E. 1980: LAi reactivity in rats immunized with tumor cells. Neoplasma 27(4): 373-377
Knobloch, V.; Jouja, V.; Svobodová, M. 1980: LAi test in pregnant women. Ceskoslovenska Gynekologie 45(1): 10-12
Soukup, K.; Jandová, A.; Heyberger, K.; Mejsnarová, B.; Motycka, K.; Coupek, J.; Trnka, V.; Kobilkovvá, J. 1981: LAi test in pregnant women having EPH toxemia. Sbornik Lekarsky 83(10): 297-299
Larisch-Bloch, S.; Sulitzeanu, D. 1993: LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s). Growth Factors 8(3): 177-186
Ronneberger, H. 1982: LAL assay for plasmaproteins. Progress in Clinical and Biological Research 93: 261-267
Carson, L.A.; Petersen, N.J. 1982: LAL-reactive material associated with hemodialysis membranes. Progress in Clinical and Biological Research 93: 217-230
Schmidt, P.F.; Fromme, H.G.; Pfefferkorn, G. 1980: LAMMA--investigations of biological and medical specimens. Scanning Electron Microscopy 1980(Part 2): 623-634
Pass, T.M. 1983: LAMP. a data management and analysis system for patient registries and clinical studies. Journal of Medical Systems 7(3): 267-271
Barris, M.C.; Dawson, W.W.; Trick, L.R. 1981: LASCER Bode plots for normal, amblyopic, and stereoanomalous observers. Documenta Ophthalmologica. Advances in Ophthalmology 51(4): 347-363
Kearns, L.A. 1995: LASIK--the future is now. Journal of Refractive Surgery 11(2): 81-82
Mehdi, Q.; Hockaday, T.D.; Newlands, E.; el-Kabir, D.J. 1971: LATS actions of bacterial permeability and protein synthesis. Proceedings of the Royal Society of Medicine 64(12): 1268-1269
Beighton, P. 1968: LATS activity, exophthalmos and digital clubbing associated with myxoedema. Postgraduate Medical Journal 44(511): 426-428
Bartholomew, C. 1972: LATS activity, hyperthyroidism, exophthalmos, pretibial myxoedema and acropachy. British Journal of Clinical Practice 26(9): 431-433
Gordon, A. 1971: LATS and Graves' disease. Harefuah 80(10): 569-570
Nauman, J.; Nauman, A. 1972: LATS and infiltrating ocular changes in Graves-Basedow's disease. Polskie Archiwum Medycyny Wewnetrznej 49(6): 597-606
Rodríguez Zapata, M.M. 1983: LATS and other antibodies against the TSH receptor. Medicina Clinica 80(4): 177-181
Hedley, A.J.; Ross, I.P.; Beck, J.S.; Donald, D.; Recht, F.A.; Michie, W.; Crooks, J. 1970: LATS and recurrent thyrotoxicosis after subtotal thyroidectomy. Clinical Science 39(3): 10P
Földes, J.; Takó, J.; Bános, C.; Gesztesi, E.; Varga, I. 1968: LATS and thyroid antibody level in the blood in Basedow's disease. Orvosi Hetilap 109(33): 1799-1804
Beall, G.N.; Solomon, D.H. 1968: LATS and thyroid autoantibodies. Clinical and Experimental Immunology 3(7): 615-619
Pinchera, A.; Liberti, P.; Frontali, M.T. 1965: LATS assays on extracts of lymphoid tissue from a thyrotoxic patient. Folia Endocrinologica 18(3): 252-256
Nauman, J.; Nauman, A. 1971: LATS in Graves-Basedow disease. Polskie Archiwum Medycyny Wewnetrznej 46(3): 315-321
Chopra, I.J.; Beall, G.N.; Solomon, D.H. 1971: LATS inhibition by a soluble lipoprotein from human thyroid gland. Journal of Clinical Endocrinology and Metabolism 32(6): 772-778
Fukuchi, M. 1969: LATS production by lymphocyte culture. Nihon Naibunpi Gakkai Zasshi 45(7): 766-777
Shishiba, Y. 1971: LATS(long-acting thyroid stimulator): recent development. Naika. Internal Medicine 28(1): 48-52
Nauman, J.; Nauman, A. 1969: LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease. Polskie Archiwum Medycyny Wewnetrznej 43(4): 1427-1432
Ochi, Y.; Hachiya, T.; Yoshimura, M.; Shiomi, K.; Miyazaki, T. 1973: LATs-induced stimulation of thyroidal glucose-6-phosphate dehydrogenase in the mouse. Japanese Journal of Physiology 23(6): 569-574
Shapiro, D.N. 1967: Reactions of children to oral surgery experience. Journal of Dentistry for Children 34(2): 97-107
Ganeshan, K.P.; Xavier, K.B. 1972: LB-46 in angina pectoris. a critique of anti-anginal drug assessment. Indian Heart Journal 24(Suppl 1): 197-120
Bisht, D.B.; Banerji, K. 1972: LB-46 in cardiac arrhythmias. Indian Heart Journal 24(Suppl 1): 205-210
Storstein, L. 1972: LB-46, a new beta-adrenergic receptor blocking agent in cardiac arrhythmias. Acta Medica Scandinavica 191(5): 423-428
Termijtelen, A.; van den Berge, S.J.; van Rood, J.J. 1983: LB-Q1 and LB-Q2: two determinants defined in the primed lymphocyte test and independent of HLA-D/DR, MB/LB-E, or SB. Human Immunology 8(1): 11-15
Langer, E. 1967: LBJ at NIH. President offers kind words for basic RESEARCH. Science 157(3787): 403-405
Hurtado, I.; Urbina, C. 1983: LC-6 inhibition of the rat skin reactions is due to mediator release inhibitor and not to mediator antagonism. Acta Cientifica Venezolana 34(1): 44-47
Tansy, M.F.; Landin, W.E.; Kendall, F.M. 1980: LC50 value for rats acutely exposed to methyl methacrylate monomer vapor. Journal of Dental Research 59(6): 1074
Oberly, R.; Tansy, M.F. 1985: LC50 values for rats acutely exposed to vapors of acrylic and methacrylic acid esters. Journal of Toxicology and Environmental Health 16(6): 811-822